UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended ~~December~~March 31, ~~2022~~2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-38932

AMCOR PLC

(Exact name of Registrant as specified in its charter)


Jersey						98-1455367
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

83 Tower Road North

Warmley, Bristol BS30 8XP

United Kingdom

(Address of principal executive offices)

Registrant’s telephone number, including area code: +44 117 9753200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Ordinary Shares, Par Value $0.01 Per Share

AMCR

New York Stock Exchange

1.125% Guaranteed Senior Notes Due 2027

AUKF/27

New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):


Large Accelerated Filer	☒	Emerging Growth Company	☐
Non-Accelerated Filer	☐	Smaller Reporting Company	☐
Accelerated Filer	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~February 6,~~May 1, 2023, the registrant had ~~1,485,779,968~~1,471,443,801 ordinary shares, $0.01 par value, outstanding.

Amcor plc

Quarterly Report on Form 10-Q

Table of Contents


Part I
Item 1.	Financial Statements (unaudited)	5
	Condensed Consolidated Statements of Income	5
	Condensed Consolidated Statements of Comprehensive Income	6
	Condensed Consolidated Balance Sheets	7
	Condensed Consolidated Statements of Cash Flows	8
	Condensed Consolidated Statements of Equity	9
	Notes to Condensed Consolidated Financial Statements	10
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3334
	Summary of Financial Results	3334
	Overview	3435
	Significant Items Affecting the Periods Presented	3435
	Results of Operations	3637
	Presentation of Non-GAAP Information	4243
	Supplemental Guarantor Information	4445
	New Accounting Pronouncements	4647
	Critical Accounting Estimates and Judgments	4647
	Liquidity and Capital Resources	4748
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	4950
Item 4.	Controls and Procedures	5051

Part II
Item 1.	Legal Proceedings	5152
Item 1A.	Risk Factors	5152
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	5152
Item 3.	Defaults Upon Senior Securities	5152
Item 4.	Mine Safety Disclosures	5152
Item 5.	Other Information	5152
Item 6.	Exhibits	5253
	Signatures	5354

Cautionary Statement Regarding Forward-Looking Statements

Unless otherwise indicated, references to "Amcor," the "Company," "we," "our," and "us" in this Quarterly Report on Form 10-Q refer to Amcor plc and its consolidated subsidiaries.

This Quarterly Report on Form 10-Q contains certain statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like "believe," "expect," "target," "project," "may," "could," "would," "approximately," "possible," "will," "should," "intend," "plan," "anticipate," "commit," "estimate," "potential," "ambitions," "outlook," or "continue," the negative of these words, other terms of similar meaning, or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers, or advisors, provide any representation, assurance, or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to:

• changes in consumer demand patterns and customer requirements in numerous industries;

• the loss of key customers, a reduction in their production requirements, or consolidation among key customers;

• significant competition in the industries and regions in which we operate;

• the inability to expand our current business effectively through either organic growth, including by product innovation, or acquisitions;

• challenging current and future global economic conditions, including inflation and supply chain disruptions;

• impact of operating internationally, including negative impacts from the Russia-Ukraine conflict;

• price fluctuations or shortages in the availability of raw materials, energy and other inputs, which could adversely affect our business;

• production, supply, and other commercial risks, including counterparty credit risks, which may be exacerbated in times of economic volatility;

• global health outbreaks, including the Coronavirus pandemic ("COVID-19");

• an inability to attract and retain key personnel;

• costs and liabilities related to current and future environment, health and safety laws and regulations;

• labor disputes;

• risks related to climate change;

• failures or disruptions in information technology systems;

• cybersecurity risks, which could disrupt our operations or risk of loss of our sensitive business information;

• a significant increase in our indebtedness or a downgrade in our credit rating could reduce our operating flexibility and increase our borrowing costs and negatively affect our financial condition and results of operations;

• foreign exchange rate risk;

• rising interest rates that increase our borrowing costs on our variable rate indebtedness and could have other negative impacts;

• a significant write-down of goodwill and/or other intangible assets;

• failure to maintain an effective system of internal control over financial reporting;

• an inability of our insurance policies, including our use of a captive insurance company, to provide adequate protection against all of the risks we face;

• an inability to defend our intellectual property rights or intellectual property infringement claims against us;

• litigation, including product liability claims, or regulatory developments;

• increasing scrutiny and changing expectations with respect to our Environmental, Social, and Governance ("ESG") practices resulting in additional costs or exposure to additional risks;

• changing government regulations in environmental, health, and safety matters; and

• changes in tax laws or changes in our geographic mix of earnings.

These risks and uncertainties are supplemented by those identified from time to time in our filings with the Securities and Exchange Commission, including without limitation, those described under Part I, "Item 1A - Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022, as updated by our quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.

Part I - Financial Information

Item 1. Financial Statements (unaudited)

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Income

(Unaudited)


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions, except per share data)	($ in millions, except per share data)	2022		2021		2022		2021		($ in millions, except per share data)	2023		2022		2023		2022
Net sales	Net sales	$	3,642	$	3,507	$	7,354	$	6,927	Net sales	$	3,667	$	3,708	$	11,021	$	10,635
Cost of sales	Cost of sales	(2,980)		(2,862)		(6,024)		(5,632)		Cost of sales	(2,994)		(2,977)		(9,018)		(8,609)

Gross profit	Gross profit	662		645		1,330		1,295		Gross profit	673		731		2,003		2,026

Selling, general, and administrative expenses	Selling, general, and administrative expenses	(298)		(303)		(600)		(616)		Selling, general, and administrative expenses	(317)		(326)		(917)		(942)
Research and development expenses	Research and development expenses	(24)		(23)		(49)		(48)		Research and development expenses	(27)		(24)		(76)		(72)
Restructuring and other related activities, net	Restructuring and other related activities, net	213		(10)		212		(18)		Restructuring and other related activities, net	(50)		(9)		162		(27)
Other income, net		6		13		8		5
Other income/(expenses), net										Other income/(expenses), net	3		(3)		11		2

Operating income	Operating income	559		322		901		618		Operating income	282		369		1,183		987

Interest income	Interest income	11		5		20		10		Interest income	15		5		35		15
Interest expense	Interest expense	(79)		(39)		(138)		(79)		Interest expense	(86)		(36)		(224)		(115)
Other non-operating income, net	Other non-operating income, net	3		2		3		7		Other non-operating income, net	2		5		5		12

Income before income taxes	Income before income taxes	494		290		786		556		Income before income taxes	213		343		999		899

Income tax expense	Income tax expense	(33)		(61)		(91)		(124)		Income tax expense	(34)		(72)		(125)		(196)

Net income	Net income	$	461	$	229	$	695	$	432	Net income	$	179	$	271	$	874	$	703

Net income attributable to non-controlling interests	Net income attributable to non-controlling interests	(2)		(4)		(4)		(5)		Net income attributable to non-controlling interests	(2)		(2)		(6)		(7)

Net income attributable to Amcor plc	Net income attributable to Amcor plc	$	459	$	225	$	691	$	427	Net income attributable to Amcor plc	$	177	$	269	$	868	$	696

Basic earnings per share:	Basic earnings per share:	$	0.309	$	0.148	$	0.465	$	0.280	Basic earnings per share:	$	0.120	$	0.178	$	0.585	$	0.457

Diluted earnings per share:	Diluted earnings per share:	$	0.307	$	0.148	$	0.461	$	0.279	Diluted earnings per share:	$	0.119	$	0.178	$	0.581	$	0.456

Note: Per share amounts may not add due to rounding. See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		2022		2021		($ in millions)	2023		2022		2023		2022
Net income	Net income	$	461	$	229	$	695	$	432	Net income	$	179	$	271	$	874	$	703
Other comprehensive income/(loss):	Other comprehensive income/(loss):									Other comprehensive income/(loss):
Net gains/(losses) on cash flow hedges, net of tax (a)	Net gains/(losses) on cash flow hedges, net of tax (a)	4		(5)		(3)		(7)		Net gains/(losses) on cash flow hedges, net of tax (a)	2		4		(1)		(3)
Foreign currency translation adjustments, net of tax (b)	Foreign currency translation adjustments, net of tax (b)	144		(21)		(17)		(116)		Foreign currency translation adjustments, net of tax (b)	43		76		26		(40)

Pension, net of tax (c)	Pension, net of tax (c)	(1)		3		(1)		3		Pension, net of tax (c)	(1)		—		(2)		3
Other comprehensive income/(loss)	Other comprehensive income/(loss)	147		(23)		(21)		(120)		Other comprehensive income/(loss)	44		80		23		(40)
Total comprehensive income	Total comprehensive income	608		206		674		312		Total comprehensive income	223		351		897		663
Comprehensive income attributable to non-controlling interests	Comprehensive income attributable to non-controlling interests	(2)		(4)		(4)		(4)		Comprehensive income attributable to non-controlling interests	(2)		(4)		(6)		(8)
Comprehensive income attributable to Amcor plc	Comprehensive income attributable to Amcor plc	$	606	$	202	$	670	$	308	Comprehensive income attributable to Amcor plc	$	221	$	347	$	891	$	655

(a) Tax benefit related to cash flow hedges		$	—	$	1	$	1	$	1
(a) Tax benefit/(expense) related to cash flow hedges										(a) Tax benefit/(expense) related to cash flow hedges	$	(1)	$	—	$	—	$	1
(b) Tax benefit/(expense) related to foreign currency translation adjustments	(b) Tax benefit/(expense) related to foreign currency translation adjustments	$	2	$	—	$	(1)	$	(2)	(b) Tax benefit/(expense) related to foreign currency translation adjustments	$	(2)	$	2	$	(3)	$	—

(c) Tax benefit related to pension adjustments	(c) Tax benefit related to pension adjustments	$	—	$	—	$	—	$	—	(c) Tax benefit related to pension adjustments	$	—	$	—	$	—	$	—

See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)


($ in millions, except share and per share data)	($ in millions, except share and per share data)	December 31, 2022		June 30, 2022		($ in millions, except share and per share data)	March 31, 2023		June 30, 2022
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	837	$	775	Cash and cash equivalents	$	564	$	775
Trade receivables, net of allowance for doubtful accounts of $23 and $25, respectively		1,972		1,935
Trade receivables, net of allowance for credit losses of $22 and $25, respectively						Trade receivables, net of allowance for credit losses of $22 and $25, respectively	2,034		1,935
Inventories, net:	Inventories, net:					Inventories, net:
Raw materials and supplies	Raw materials and supplies	1,205		1,114		Raw materials and supplies	1,118		1,114
Work in process and finished goods	Work in process and finished goods	1,304		1,325		Work in process and finished goods	1,302		1,325
Prepaid expenses and other current assets	Prepaid expenses and other current assets	545		512		Prepaid expenses and other current assets	570		512
Assets held for sale, net	Assets held for sale, net	—		192		Assets held for sale, net	—		192
Total current assets	Total current assets	5,863		5,853		Total current assets	5,588		5,853
Non-current assets:	Non-current assets:					Non-current assets:

Property, plant, and equipment, net	Property, plant, and equipment, net	3,687		3,646		Property, plant, and equipment, net	3,741		3,646
Operating lease assets	Operating lease assets	543		560		Operating lease assets	534		560
Deferred tax assets	Deferred tax assets	129		130		Deferred tax assets	136		130
Other intangible assets, net	Other intangible assets, net	1,577		1,657		Other intangible assets, net	1,548		1,657
Goodwill	Goodwill	5,281		5,285		Goodwill	5,338		5,285
Employee benefit assets	Employee benefit assets	91		89		Employee benefit assets	93		89
Other non-current assets	Other non-current assets	304		206		Other non-current assets	300		206
Total non-current assets	Total non-current assets	11,612		11,573		Total non-current assets	11,690		11,573
Total assets	Total assets	$	17,475	$	17,426	Total assets	$	17,278	$	17,426
Liabilities	Liabilities					Liabilities
Current liabilities:	Current liabilities:					Current liabilities:
Current portion of long-term debt	Current portion of long-term debt	$	14	$	14	Current portion of long-term debt	$	13	$	14
Short-term debt	Short-term debt	48		136		Short-term debt	196		136
Trade payables	Trade payables	2,785		3,073		Trade payables	2,528		3,073
Accrued employee costs	Accrued employee costs	344		471		Accrued employee costs	359		471
Other current liabilities	Other current liabilities	1,202		1,344		Other current liabilities	1,312		1,344
Liabilities held for sale	Liabilities held for sale	—		65		Liabilities held for sale	—		65
Total current liabilities	Total current liabilities	4,393		5,103		Total current liabilities	4,408		5,103
Non-current liabilities:	Non-current liabilities:					Non-current liabilities:
Long-term debt, less current portion	Long-term debt, less current portion	6,840		6,340		Long-term debt, less current portion	6,804		6,340
Operating lease liabilities	Operating lease liabilities	476		493		Operating lease liabilities	466		493
Deferred tax liabilities	Deferred tax liabilities	667		677		Deferred tax liabilities	644		677
Employee benefit obligations	Employee benefit obligations	200		201		Employee benefit obligations	199		201
Other non-current liabilities	Other non-current liabilities	488		471		Other non-current liabilities	449		471
Total non-current liabilities	Total non-current liabilities	8,671		8,182		Total non-current liabilities	8,562		8,182
Total liabilities	Total liabilities	13,064		13,285		Total liabilities	12,970		13,285

Commitments and contingencies (See Note 15)
Commitments and contingencies (See Note 16)						Commitments and contingencies (See Note 16)

Shareholders' Equity	Shareholders' Equity					Shareholders' Equity
Amcor plc shareholders’ equity:	Amcor plc shareholders’ equity:					Amcor plc shareholders’ equity:
Ordinary shares ($0.01 par value)	Ordinary shares ($0.01 par value)					Ordinary shares ($0.01 par value)
Authorized (9,000 million shares)	Authorized (9,000 million shares)					Authorized (9,000 million shares)
Issued (1,486 and 1,489 million shares, respectively)		$	15	$	15
Issued (1,471 and 1,489 million shares, respectively)						Issued (1,471 and 1,489 million shares, respectively)	$	15	$	15
Additional paid-in capital	Additional paid-in capital	4,391		4,431		Additional paid-in capital	4,241		4,431
Retained earnings	Retained earnings	866		534		Retained earnings	863		534
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(901)		(880)		Accumulated other comprehensive loss	(857)		(880)
Treasury shares (2 and 2 million shares, respectively)		(18)		(18)
Treasury shares (1 and 2 million shares, respectively)						Treasury shares (1 and 2 million shares, respectively)	(14)		(18)
Total Amcor plc shareholders' equity	Total Amcor plc shareholders' equity	4,353		4,082		Total Amcor plc shareholders' equity	4,248		4,082
Non-controlling interests	Non-controlling interests	58		59		Non-controlling interests	60		59
Total shareholders' equity	Total shareholders' equity	4,411		4,141		Total shareholders' equity	4,308		4,141
Total liabilities and shareholders' equity	Total liabilities and shareholders' equity	$	17,475	$	17,426	Total liabilities and shareholders' equity	$	17,278	$	17,426

See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)


		Six Months Ended December 31,					Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		($ in millions)	2023		2022
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income	Net income	$	695	$	432	Net income	$	874	$	703
Adjustments to reconcile net income to net cash provided by operating activities:	Adjustments to reconcile net income to net cash provided by operating activities:					Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization, and impairment	Depreciation, amortization, and impairment	284		332		Depreciation, amortization, and impairment	428		479
Net periodic benefit cost	Net periodic benefit cost	4		4		Net periodic benefit cost	6		5
Amortization of debt discount and deferred financing costs	Amortization of debt discount and deferred financing costs	1		1		Amortization of debt discount and deferred financing costs	1		2

Net gain on disposal of property, plant, and equipment	Net gain on disposal of property, plant, and equipment	(5)		—		Net gain on disposal of property, plant, and equipment	(5)		—
Net gain on disposal of businesses	Net gain on disposal of businesses	(219)		—		Net gain on disposal of businesses	(219)		—

Net foreign exchange (gain)/loss	Net foreign exchange (gain)/loss	25		(2)		Net foreign exchange (gain)/loss	29		(3)
Share-based compensation	Share-based compensation	29		31		Share-based compensation	42		47
Other, net	Other, net	11		57		Other, net	42		114
Loss from hyperinflationary accounting for Argentine subsidiaries	Loss from hyperinflationary accounting for Argentine subsidiaries	28		7		Loss from hyperinflationary accounting for Argentine subsidiaries	43		14
Deferred income taxes, net	Deferred income taxes, net	(12)		(14)		Deferred income taxes, net	(43)		(44)

Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency	Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency	(696)		(525)		Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency	(869)		(728)
Net cash provided by operating activities	Net cash provided by operating activities	145		323		Net cash provided by operating activities	329		589
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Issuance of loans to affiliated companies and other	Issuance of loans to affiliated companies and other	(1)		(5)		Issuance of loans to affiliated companies and other	(1)		(5)
Investments in affiliated companies and other	Investments in affiliated companies and other	(49)		(11)		Investments in affiliated companies and other	(55)		(11)
Business acquisitions	Business acquisitions	(54)		—		Business acquisitions	(88)		—
Purchase of property, plant, and equipment, and other intangible assets	Purchase of property, plant, and equipment, and other intangible assets	(250)		(255)		Purchase of property, plant, and equipment, and other intangible assets	(382)		(373)
Proceeds from divestitures		370		—
(Payments)/proceeds from divestitures						(Payments)/proceeds from divestitures	365		(1)
Proceeds from sales of property, plant, and equipment, and other intangible assets	Proceeds from sales of property, plant, and equipment, and other intangible assets	8		6		Proceeds from sales of property, plant, and equipment, and other intangible assets	12		7
Net cash (used in)/provided by investing activities		24		(265)
Net cash used in investing activities						Net cash used in investing activities	(149)		(383)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from issuance of shares	Proceeds from issuance of shares	132		92		Proceeds from issuance of shares	133		92

Purchase of treasury shares	Purchase of treasury shares	(221)		(133)		Purchase of treasury shares	(221)		(133)

Proceeds from issuance of long-term debt	Proceeds from issuance of long-term debt	—		19		Proceeds from issuance of long-term debt	23		570
Repayment of long-term debt	Repayment of long-term debt	(11)		(677)		Repayment of long-term debt	(334)		(678)
Net borrowing of commercial paper	Net borrowing of commercial paper	500		1,133		Net borrowing of commercial paper	717		1,248
Net repayment of short-term debt		(83)		(4)
Net borrowing/(repayment) of short-term debt						Net borrowing/(repayment) of short-term debt	58		(72)
Repayment of lease liabilities	Repayment of lease liabilities	(2)		(2)		Repayment of lease liabilities	(3)		(2)
Share buyback/cancellations		(40)		(295)
Share buybacks/cancellations						Share buybacks/cancellations	(200)		(423)
Dividends paid	Dividends paid	(365)		(368)		Dividends paid	(545)		(550)
Net cash used in financing activities		(90)		(235)
Net cash provided by/(used in) financing activities						Net cash provided by/(used in) financing activities	(372)		52

Effect of exchange rates on cash and cash equivalents	Effect of exchange rates on cash and cash equivalents	(92)		(47)		Effect of exchange rates on cash and cash equivalents	(94)		(31)

Net decrease in cash and cash equivalents		(13)		(224)
Net increase/(decrease) in cash and cash equivalents						Net increase/(decrease) in cash and cash equivalents	(286)		227
Cash and cash equivalents balance at beginning of year	Cash and cash equivalents balance at beginning of year	850		850		Cash and cash equivalents balance at beginning of year	850		850

Cash and cash equivalents balance at end of period	Cash and cash equivalents balance at end of period	$	837	$	626	Cash and cash equivalents balance at end of period	$	564	$	1,077

Supplemental cash flow information:	Supplemental cash flow information:					Supplemental cash flow information:
Interest paid, net of amounts capitalized	Interest paid, net of amounts capitalized	$	127	$	70	Interest paid, net of amounts capitalized	$	202	$	99
Income taxes paid	Income taxes paid	$	91	$	110	Income taxes paid	$	130	$	163

Supplemental non-cash disclosures relating to investing and financing activities:	Supplemental non-cash disclosures relating to investing and financing activities:					Supplemental non-cash disclosures relating to investing and financing activities:
Purchase of property and equipment, accrued but unpaid		$	83	$	74
Purchase of property, plant, and equipment, accrued but unpaid						Purchase of property, plant, and equipment, accrued but unpaid	$	69	$	85
Business acquisitions, accrued but unpaid						Business acquisitions, accrued but unpaid	$	26	$	—

See accompanying notes to condensed consolidated financial statements. Cash and cash equivalents at the beginning of the year include cash and cash equivalents classified as held for sale.

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Equity

(Unaudited)


($ in millions, except per share data)	($ in millions, except per share data)	Ordinary Shares		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Shares		Non-controlling Interests		Total		($ in millions, except per share data)	Ordinary Shares		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Shares		Non-controlling Interests		Total
Balance as of September 30, 2021		$	15	$	5,074	$	473	$	(862)	$	(50)	$	55	$	4,705
Balance as of December 31, 2021																Balance as of December 31, 2021	$	15	$	4,854	$	515	$	(885)	$	(37)	$	57	$	4,519
Net income	Net income					225						4		229		Net income					269						2		271
Other comprehensive loss								(23)				—		(23)
Other comprehensive income																Other comprehensive income							78				2		80
Share buyback/cancellations	Share buyback/cancellations	—		(231)										(231)		Share buyback/cancellations	—		(128)										(128)
Dividends declared ($0.12 per share)	Dividends declared ($0.12 per share)					(183)						(2)		(185)		Dividends declared ($0.12 per share)					(180)						(2)		(182)
Options exercised and shares vested				(5)						15				10

Purchase of treasury shares										(2)				(2)

Share-based compensation expense				16										16

Balance as of December 31, 2021		$	15	$	4,854	$	515	$	(885)	$	(37)	$	57	$	4,519

Balance as of June 30, 2021		$	15	$	5,092	$	452	$	(766)	$	(29)	$	57	$	4,821
Net income						427						5		432
Other comprehensive loss								(119)				(1)		(120)
Share buyback/cancellations		—		(295)										(295)
Dividends declared ($0.2375 per share)						(364)						(4)		(368)
Options exercised and shares vested	Options exercised and shares vested			(33)						125				92		Options exercised and shares vested			(2)						2				—
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax	Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			59										59		Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			—										—
Purchase of treasury shares	Purchase of treasury shares									(133)				(133)		Purchase of treasury shares									—				—

Share-based compensation expense	Share-based compensation expense			31										31		Share-based compensation expense			16										16
Change in non-controlling interests																Change in non-controlling interests			—								1		1

Balance as of March 31, 2022																Balance as of March 31, 2022	$	15	$	4,740	$	604	$	(807)	$	(35)	$	60	$	4,577

Balance as of December 31, 2021		$	15	$	4,854	$	515	$	(885)	$	(37)	$	57	$	4,519
Balance as of June 30, 2021																Balance as of June 30, 2021	$	15	$	5,092	$	452	$	(766)	$	(29)	$	57	$	4,821
Net income																Net income					696						7		703
Other comprehensive income/(loss)																Other comprehensive income/(loss)							(41)				1		(40)
Share buyback/cancellations																Share buyback/cancellations	—		(423)										(423)
Dividends declared ($0.3575 per share)																Dividends declared ($0.3575 per share)					(544)						(6)		(550)
Options exercised and shares vested																Options exercised and shares vested			(35)						127				92
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax																Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			59										59
Purchase of treasury shares																Purchase of treasury shares									(133)				(133)

Balance as of September 30, 2022		$	15	$	4,412	$	588	$	(1,048)	$	(49)	$	58	$	3,976
Share-based compensation expense																Share-based compensation expense			47										47
Change in non-controlling interests																Change in non-controlling interests			—								1		1

Balance as of March 31, 2022																Balance as of March 31, 2022	$	15	$	4,740	$	604	$	(807)	$	(35)	$	60	$	4,577

Balance as of December 31, 2022																Balance as of December 31, 2022	$	15	$	4,391	$	866	$	(901)	$	(18)	$	58	$	4,411
Net income	Net income					459						2		461		Net income					177						2		179
Other comprehensive income	Other comprehensive income							147				—		147		Other comprehensive income							44				—		44
Share buyback/cancellations	Share buyback/cancellations	—		(40)										(40)		Share buyback/cancellations	—		(160)										(160)
Dividends declared ($0.1225 per share)	Dividends declared ($0.1225 per share)					(181)						(3)		(184)		Dividends declared ($0.1225 per share)					(180)						—		(180)
Options exercised and shares vested	Options exercised and shares vested			(14)						50				36		Options exercised and shares vested			(3)						4				1
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax	Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			20										20		Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			—										—
Purchase of treasury shares	Purchase of treasury shares									(19)				(19)		Purchase of treasury shares									—				—
Share-based compensation expense	Share-based compensation expense			13										13		Share-based compensation expense			13										13
Change in non-controlling interests	Change in non-controlling interests											1		1		Change in non-controlling interests											—		—

Balance as of December 31, 2022		$	15	$	4,391	$	866	$	(901)	$	(18)	$	58	$	4,411
Balance as of March 31, 2023																Balance as of March 31, 2023	$	15	$	4,241	$	863	$	(857)	$	(14)	$	60	$	4,308

Balance as of June 30, 2022	Balance as of June 30, 2022	$	15	$	4,431	$	534	$	(880)	$	(18)	$	59	$	4,141	Balance as of June 30, 2022	$	15	$	4,431	$	534	$	(880)	$	(18)	$	59	$	4,141
Net income	Net income					691						4		695		Net income					868						6		874
Other comprehensive loss								(21)				—		(21)
Other comprehensive income																Other comprehensive income							23				—		23
Share buyback/cancellations	Share buyback/cancellations	—		(40)										(40)		Share buyback/cancellations	—		(200)										(200)
Dividends declared ($0.2425 per share)						(359)						(6)		(365)
Dividends declared ($0.365 per share)																Dividends declared ($0.365 per share)					(539)						(6)		(545)
Options exercised and shares vested	Options exercised and shares vested			(89)						221				132		Options exercised and shares vested			(92)						225				133
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax	Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			60										60		Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax			60										60
Purchase of treasury shares	Purchase of treasury shares									(221)				(221)		Purchase of treasury shares									(221)				(221)
Share-based compensation expense	Share-based compensation expense			29										29		Share-based compensation expense			42										42
Change in non-controlling interests	Change in non-controlling interests											1		1		Change in non-controlling interests											1		1

Balance as of December 31, 2022		$	15	$	4,391	$	866	$	(901)	$	(18)	$	58	$	4,411
Balance as of March 31, 2023																Balance as of March 31, 2023	$	15	$	4,241	$	863	$	(857)	$	(14)	$	60	$	4,308

See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Note 1 - Nature of Operations and Basis of Presentation

Amcor plc ("Amcor" or the "Company") is a public limited company incorporated under the Laws of the Bailiwick of Jersey. The Company's history dates back more than 150 years, with origins in both Australia and the United States of America. Today, Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other consumer goods end markets. The Company's innovation excellence and global packaging expertise enable the Company to solve packaging challenges around the world every day, producing packaging that is more functional, appealing, and cost effective for its customers and their consumers and importantly, more sustainable for the environment.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information. Consistent with these requirements, this Form 10-Q does not include all the information required by U.S. GAAP for complete financial statements. Further, the year-end condensed consolidated balance sheet data as of June 30, 2022 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. It is management's opinion, however, that all material and recurring adjustments have been made that are necessary for a fair statement of its interim financial position, results of operations, and cash flows. For further information, this Form 10-Q should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

There have been no material changes to the accounting policies followed by the Company during the current fiscal year. The Company reclassified prior year inventory comparatives in the condensed consolidated balance sheets to conform to the current year's presentation which provides the breakdown of inventory. This change in presentation did not have an impact on the Company’s financial condition or operating results. Certain amounts in the Company's notes to unaudited condensed consolidated financial statements may not add or recalculate due to rounding.

Note 2 - New Accounting Guidance

Recently Adopted Accounting Standards

In November 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2021-10, Government Assistance (Topic 832) that adds certain disclosure requirements for entities that receive government assistance. The standard is effective for annual periods beginning after December 15, 2021 with early adoption permitted. The Company adopted ASU 2021-10 on July 1, 2022, and the adoption did not have a material impact on the Company's condensed consolidated financial statements. ASU 2021-10 may have an impact on the Company’s disclosures in the future, if government assistance provided to the Company were to become material.

Accounting Standards Not Yet Adopted

In September 2022, the FASB issued ASU 2022-04 that adds certain disclosure requirements for entities that use supplier finance programs in connection with the purchase of goods and services. The new standard's requirement to disclose the key terms of supplier finance programs is effective for all interim and annual periods beginning with the Company's fiscal year ending June 30, 2024. The new standard does not affect the recognition, measurement, or financial statement presentation of supplier finance program obligations. Early adoption is permitted. The Company ~~is currently evaluating the impact that~~will adopt this new disclosure guidance ~~may have on its consolidated financial statements.~~in the first quarter of fiscal year 2024.

The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined at this time that all other ASUs not yet adopted are either not applicable or are not expected to have a material impact on its results of operation, financial position, and disclosures.

Note 3 - Restructuring and Other Related Activities, Net

Restructuring and other related activities, net, as reported on the unaudited condensed consolidated statements of income are summarized as follows:


		Three Months Ended December 31,				Six Months Ended December 31,				Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		2022		2021			($ in millions)	2023			2022		2023		2022
Gain on disposal of Russian business, net	Gain on disposal of Russian business, net	$	215	$	—	$	215	$	—		Gain on disposal of Russian business, net	$	—		$	—	$	215	$	—
Restructuring and related expenses, net	Restructuring and related expenses, net	(2)		(10)		(3)		(18)			Restructuring and related expenses, net	(50)			(9)		(53)		(27)
Restructuring and other related activities, net	Restructuring and other related activities, net	$	213	$	(10)	$	212	$	(18)		Restructuring and other related activities, net	$	(50)		$	(9)	$	162	$	(27)

A pre-tax net gain on disposal of the Company's three manufacturing facilities in Russia ("Russian business") of $215 million was recognized in the ~~three and six~~nine months ended ~~December~~March 31, ~~2022, which includes a reversal~~2023. The carrying value of athe Russian business had previously been impaired by $90 million ~~impairment charge recorded~~ in the quarter ended June 30, 2022. For further information, refer to Note 4, "Held for Sale" and Note 5, "Acquisitions and Disposals."

Refer to Note 6, "Restructuring" for information on restructuring and related expenses, net. ~~For information on the Company's future restructuring initiatives related to the sale of the Russian business announced on February 7, 2023, refer to Note 16, "Subsequent Events."~~

Note 4 - Held for Sale

During the fourth quarter of fiscal year 2022, the Company classified the assets and liabilities of its Russian operations as held for sale as a result of the Company's decision to sell its Russian business, and recorded an impairment of $90 million. On December 23, 2022, the Company completed the sale of the Russian business and derecognized the assets and liabilities previously classified as held for sale. The disposal did not represent a strategic shift that had a major effect on the Company's operations and financial results, and therefore did not qualify for reporting as a discontinued operation. The Russian business was part of the Company's Flexibles reportable segment. For further information, refer to Note 5, "Acquisitions and Disposals."

Major classes of assets and liabilities of the Russian business classified as held for sale were as follows:


($ in millions)	~~December~~March 31, ~~2022~~2023		June 30, 2022
Cash and cash equivalents	$	—	$	75
Trade receivables, net	—		66
Inventories, net	—		40
Prepaid expenses and other current assets	—		36
Property, plant, and equipment, net	—		49
Goodwill	—		16
Total assets held for sale	—		282
Less accumulated impairment (1)	—		(90)
Total assets held for sale, net	$	—	$	192

Trade payables	—		65
Total current liabilities held for sale	$	—	$	65

(1) Inclusive of accumulated other comprehensive loss related to the Russian business.

This table excludes other non-material assets and liabilities that are held for sale but not part of the Russian business.

Note 5 - Acquisitions and Disposals

~~Acquisitions~~Acquisition of DGPack s.r.o

On August 1, 2022, the Company completed the acquisition of 100% equity interest in DGPack s.r.o., a Czech Republic company that operates a world-class flexible packaging manufacturing plant. The ~~initial~~ purchase consideration amounted to $60 million and is subject to customary post-closing adjustments. The consideration includes $6 million that is expected to be paid in the ~~third~~fourth quarter of fiscal year 2023. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired identifiable net assets of $36 million and goodwill of $24 million. Goodwill is not deductible for tax purposes. The fair values of the identifiable net assets acquired and goodwill are based on the Company's best estimate as of ~~December~~March 31, ~~2022~~2023 and are considered preliminary. The fair value estimates were based on income, market, and cost valuation methods. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the acquisition.

Pro forma information related to the acquisition of DGPack s.r.o. has not been presented, as the effect of the acquisition on the Company's consolidated financial statements was not material.

~~Disposals~~Acquisition of MDK Packaging Materials Co., Ltd

On March 17, 2023, the Company completed the acquisition of 100% equity interest in MDK Packaging Materials Co., Ltd that operates a medical device packaging manufacturing site in Shanghai, China. The purchase consideration amounted to $60 million and is subject to customary post-closing adjustments. The consideration includes contingent consideration of $20 million, to be earned and paid in cash over the three years following the acquisition date, subject to meeting certain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired identifiable net assets of $20 million and goodwill of $40 million. Goodwill is not deductible for tax purposes. The fair values of the contingent consideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of March 31, 2023 and are considered preliminary. The fair value estimates were based on income, market, and cost valuation methods. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the acquisition.

Pro forma information related to the acquisition of MDK Packaging Materials Co., Ltd. has not been presented, as the effect of the acquisition on the Company's consolidated financial statements was not material.

Disposal of Russian business

On December 23, 2022, the Company completed the sale of the Russian business after receiving all necessary regulatory approvals and cash proceeds, including receipt of closing cash balances. The sale follows the Company’s previously announced plan to pursue the orderly sale of its Russian business. The total net cash consideration received, excluding disposed cash and items settled net, was $365 million and resulted in a ~~net~~ pre-tax net gain of $215 ~~million, which included a reversal~~million. The carrying value of athe Russian business had previously been impaired by $90 million ~~impairment charge recorded~~ in the ~~fourth~~ quarter ~~of fiscal year~~ended June 30, 2022. The impairment charge was based on the Company's best estimate of the fair value of its Russian business, which considered the wide range of indicative bids received and uncertain regulatory environment. The net pre-tax gain on disposal of the Russian business was recorded as restructuring and other related activities, net within the unaudited condensed consolidated statements of income. The Russian business had a net carrying value of $252 million, including allocated goodwill of $46 million and accumulated other comprehensive losses of $73 million, primarily attributed to foreign currency translation adjustments.

Note 6 - Restructuring

The Company's restructuring activities in the three and six months ended December 31, 2022 were primarily comprised of restructuring activities related to the Russia-Ukraine conflict and the three and six months ended December 31, 2021 included expenses related to the Company's 2019 plan from the integration of acquired Bemis operations which was substantially completed at the end of fiscal year 2022.

Restructuring and related expenses, net were $2$50 million and ~~$10~~$9 million during the three months ended ~~December~~March 31, 2023 and 2022, respectively, and ~~2021, and $3~~$53 million and ~~$18~~$27 million in the ~~six~~nine months ended ~~December~~March 31, 2023 and 2022, ~~and 2021, respectively, and primarily relate to the Flexibles reportable segment.~~respectively. The net expenses related to restructuring activities have been presented on the unaudited condensed consolidated statements of income as restructuring and other related activities, net. The Company's restructuring activities in the three and nine months ended March 31, 2023 primarily comprised of restructuring activities related to the 2023 Restructuring Plan (as defined below). The Company's restructuring activities in the three and nine months ended March 31, 2022 included expenses related to the Company's 2019 plan from the integration of the acquired Bemis operations, which was substantially completed at the end of fiscal year 2022.

2023 Restructuring Plan

On February 7, 2023, the Company announced that it will allocate approximately $110 million to $130 million of the sale proceeds from the Russian business to various cost saving initiatives to partly help offsetting divested earnings from the Russian business (the "2023 Restructuring Plan" or the "Plan"). Under this Plan, the Company has initiated in the third quarter of fiscal year 2023 projects with an expected cost of approximately $95 million, of which $42 million relates to employee-related expenses, $20 million to fixed asset related expenses, $23 million to other restructuring expenses, and $10 million to restructuring related expenses. Of the total Plan cost initiated in the third quarter of fiscal year 2023, approximately $50 million is expected to result in net cash expenditures. The Plan includes both the Flexibles and Rigid Packaging reportable segments and is expected to be substantially completed by the end of fiscal year 2024.

As of March 31, 2023, as part of this Plan, the Company has incurred $37 million in employee-related expenses, $1 million in fixed asset related expenses, $2 million in other restructuring, and $2 million in restructuring related expenses, with $36 million incurred in the Flexibles reportable segment and $6 million incurred in the Rigid Packaging reportable segment. To date, the Plan has resulted in approximately $7 million in cash outflows. The Company continues to evaluate different options to partly offset divested earnings from the Russian business across its global footprint and expects to disclose the total Plan cost at the end of fiscal year 2023.

Restructuring related expenses are directly attributable to restructuring activities; however, they do not qualify for special accounting treatment as exit or disposal activities. The Company believes the disclosure of restructuring related costs provides more information on the total cost of the 2023 Restructuring Plan. The restructuring related costs relate primarily to the closure of facilities and include costs to replace graphics, train new employees on relocated equipment, and other startup costs.

Other Restructuring Plans

The Company has entered into other individually immaterial restructuring plans ("Other Restructuring Plans"). The Company's other restructuring charges are primarily employee costs.

An analysis of the Company's restructuring plan liability is as follows:


($ in millions)	($ in millions)	Employee Costs		Fixed Asset Related Costs		Other Costs		Total Restructuring Costs		($ in millions)	Employee Costs		Fixed Asset Related Costs		Other Costs		Total Restructuring Costs
Liability balance at June 30, 2022		$	97	$	3	$	18	$	118
Liability balance as of June 30, 2022										Liability balance as of June 30, 2022	$	97	$	3	$	18	$	118
Net charges to earnings(1)	Net charges to earnings(1)	2		—		—		2		Net charges to earnings(1)	37		4		8		49

Cash paid	Cash paid	(16)		(1)		(8)		(25)		Cash paid	(25)		(1)		(14)		(40)
Reversal of unused amounts		(2)		—		—		(2)

Liability balance at December 31, 2022		$	81	$	2	$	10	$	93
Non-cash and other										Non-cash and other	—		(3)		—		(3)
Foreign currency translation										Foreign currency translation	3		—		1		4
Liability balance as of March 31, 2023										Liability balance as of March 31, 2023	$	112	$	3	$	13	$	128

(1)Excludes $4 million of restructuring related expenses incurred in the nine months ended March 31, 2023.

The table above includes liabilities arising from the 2023 Restructuring Plan and Other Restructuring Plans.

The Company expects the majority of the liability for employee, fixed assets related, and other costs as of ~~December~~March 31, ~~2022~~2023 to be paid within the next twelve months. The accruals related to restructuring activities have been recorded on the unaudited condensed consolidated balance sheets under other current liabilities and other non-current liabilities.

Note 7 - Goodwill and Other Intangible Assets, Net

Goodwill

Changes in the carrying amount of goodwill attributable to each reportable segment, excluding amounts that were classified as held for sale as of June 30, 2022, were as follows:


($ in millions)	($ in millions)	Flexibles Segment		Rigid Packaging Segment		Total		($ in millions)	Flexibles Segment		Rigid Packaging Segment		Total
Balance as of June 30, 2022	Balance as of June 30, 2022	$	4,307	$	978	$	5,285	Balance as of June 30, 2022	$	4,307	$	978	$	5,285
Acquisitions(1)	Acquisitions(1)	24		—		24		Acquisitions(1)	64		—		64
Disposals ~~(1)~~(2)	Disposals ~~(1)~~(2)	(30)		—		(30)		Disposals ~~(1)~~(2)	(30)		—		(30)
Foreign currency translation	Foreign currency translation	7		(5)		2		Foreign currency translation	24		(5)		19
Balance as of December 31, 2022		$	4,308	$	973	$	5,281
Balance as of March 31, 2023								Balance as of March 31, 2023	$	4,365	$	973	$	5,338

(1)Acquisitions are attributed to goodwill recognized in connection with the business combinations detailed in Note 5, "Acquisitions and Disposals."

(2)Disposals are attributed to additional goodwill allocated to the Russian business, following the disposal of the business on December 23, 2022. As of June 30, 2022, $16 million of goodwill attributable to the Russian business was classified as assets held for sale. For further information, refer to Note 4, "Held for Sale" and Note 5, "Acquisitions and Disposals."

Goodwill is not amortized but is tested for impairment annually in the fourth quarter of the fiscal year, or during interim periods if events or circumstances arise which indicate that goodwill may be impaired.

Other Intangible Assets, Net

Other intangible assets, net were comprised of the following:


		December 31, 2022							March 31, 2023
($ in millions)	($ in millions)	Gross Carrying Amount		Accumulated Amortization and Impairment (1)		Net Carrying Amount		($ in millions)	Gross Carrying Amount		Accumulated Amortization and Impairment (1)		Net Carrying Amount
Customer relationships	Customer relationships	$	1,971	$	(594)	$	1,377	Customer relationships	$	1,979	$	(628)	$	1,351
Computer software	Computer software	242		(170)		72		Computer software	249		(180)		69
Other (2)	Other (2)	324		(196)		128		Other (2)	326		(198)		128
Total other intangible assets	Total other intangible assets	$	2,537	$	(960)	$	1,577	Total other intangible assets	$	2,554	$	(1,006)	$	1,548


	June 30, 2022
($ in millions)	Gross Carrying Amount		Accumulated Amortization and Impairment (1)		Net Carrying Amount
Customer relationships	$	1,970	$	(529)	$	1,441
Computer software	235		(162)		73
Other (2)	323		(180)		143
Total other intangible assets	$	2,528	$	(871)	$	1,657

(1)Accumulated amortization and impairment included $34 million and $33 million for ~~December~~March 31, ~~2022~~2023 and June 30, 2022, respectively, of accumulated impairment in the Other category.

(2)Other included $17 million and $16 million for ~~December~~March 31, ~~2022~~2023 and June 30, 2022, respectively, of acquired intellectual property assets not yet being amortized as the related R&D projects have not yet been completed.

Amortization expenses for intangible assets were $43 million and $45 million during the three months ended ~~December~~March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$87~~$130 million and ~~$90~~$135 million during the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021,~~2022, respectively.

Note 8 - Fair Value Measurements

The fair values of the Company's financial assets and financial liabilities listed below reflect the amounts that would be received to sell the assets or paid to transfer the liabilities in an orderly transaction between market participants at the measurement date (exit price).

The Company's non-derivative financial instruments primarily include cash and cash equivalents, trade receivables, trade payables, short-term debt, and long-term debt. As of ~~December~~March 31, ~~2022~~2023 and June 30, 2022, the carrying value of these financial instruments, excluding long-term debt, approximated fair value because of the short-term nature of these instruments.

The carrying value of long-term debt with variable interest rates approximates its fair value. The fair value of the Company's long-term debt with fixed interest rates is based on market prices, if available, or expected future cash flows discounted at the current interest rate for financial liabilities with similar risk profiles.

The carrying value and estimated fair value of long-term debt with fixed interest rates (including the effect of receive-fixed/pay-variable interest rate swaps) were as follows:


		December 31, 2022						June 30, 2022							March 31, 2023						June 30, 2022
		Carrying Value			Fair Value			Carrying Value			Fair Value				Carrying Value			Fair Value			Carrying Value			Fair Value
($ in millions)	($ in millions)		(Level 2)						(Level 2)		($ in millions)					(Level 2)						(Level 2)
Total long-term debt with fixed interest rates (excluding commercial paper and finance leases)	Total long-term debt with fixed interest rates (excluding commercial paper and finance leases)		$	3,941		$	3,651		$	3,952		$	3,694	Total long-term debt with fixed interest rates (excluding commercial paper and finance leases)		$	3,645		$	3,342		$	3,952		$	3,694

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

Additionally, the Company measures and records certain assets and liabilities, including derivative instruments and contingent purchase consideration liabilities, at fair value. The following table summarizes the fair value of these instruments, which are measured at fair value on a recurring basis, by level, within the fair value hierarchy:


		December 31, 2022									March 31, 2023
($ in millions)	($ in millions)	Level 1		Level 2		Level 3		Total		($ in millions)	Level 1		Level 2		Level 3		Total
Assets	Assets									Assets
Commodity contracts		$	—	$	1	$	—	$	1

Forward exchange contracts	Forward exchange contracts	—		8		—		8		Forward exchange contracts	—		8		—		8
Interest rate swaps	Interest rate swaps	—		1		—		1		Interest rate swaps	—		7		—		7

Total assets measured at fair value	Total assets measured at fair value	$	—	$	10	$	—	$	10	Total assets measured at fair value	$	—	$	15	$	—	$	15

Liabilities	Liabilities									Liabilities
Contingent purchase consideration liabilities	Contingent purchase consideration liabilities	$	—	$	—	$	15	$	15	Contingent purchase consideration liabilities	$	—	$	—	$	36	$	36
Commodity contracts	Commodity contracts	—		1		—		1		Commodity contracts	—		1		—		1
Forward exchange contracts	Forward exchange contracts	—		11		—		11		Forward exchange contracts	—		3		—		3

Interest rate swaps	Interest rate swaps	—		97		—		97		Interest rate swaps	—		83		—		83
Total liabilities measured at fair value	Total liabilities measured at fair value	$	—	$	109	$	15	$	124	Total liabilities measured at fair value	$	—	$	87	$	36	$	123


	June 30, 2022
($ in millions)	Level 1		Level 2		Level 3		Total
Assets
Commodity contracts	$	—	$	6	$	—	$	6
Forward exchange contracts	—		7		—		7

Total assets measured at fair value	$	—	$	13	$	—	$	13

Liabilities
Contingent purchase consideration liabilities	$	—	$	—	$	16	$	16
Commodity contracts	—		3		—		3
Forward exchange contracts	—		17		—		17
Interest rate swaps	—		69		—		69

Total liabilities measured at fair value	$	—	$	89	$	16	$	105

The fair value of the commodity contracts was determined using a discounted cash flow analysis based on the terms of the contracts and observed market forward prices discounted at a currency specific rate. Forward exchange contract fair values were determined based on quoted prices for similar assets and liabilities in active markets using inputs such as currency rates and forward points. The fair value of the interest rate swaps was determined using a discounted cash flow method based on market based swap yield curves, taking into account current interest rates.

Contingent purchase consideration liabilities arise from business acquisitions. As of ~~December~~March 31, ~~2022,~~2023, the Company's contingent purchase consideration liabilities of $36 million consisted of $26 million relating to consideration for business acquisitions where payments are contingent on the Company vacating a $9certain property or meeting certain performance targets. Included in the previously mentioned $26 million are $20 million of contingent consideration relating to a current period acquisition (refer to Note 5, "Acquisitions and Disposals"). The remaining $10 million liability ~~that~~ is contingent on future royalty income generated by Discma AG, a subsidiary acquired in March ~~2017, and a $6 million balance relating to consideration for small business acquisitions where payments are contingent on the Company vacating a certain property or performance criteria.~~2017. The fair value of the contingent purchase consideration liabilities was determined for each arrangement individually. The fair value was determined using the income approach with significant inputs that are not observable in the market. Key assumptions include the discount rates consistent with the level of risk of achievement and probability adjusted financial projections. The expected outcomes are recorded at net present value, which ~~requires~~require adjustment over the life for changes in risks and probabilities. Changes arising from modifications in forecasts related to contingent consideration are expected to be immaterial.

The fair value of contingent purchase consideration liabilities is included in other current liabilities and other non-current liabilities in the unaudited condensed consolidated balance sheets.

Assets and Liabilities Measured and Recorded at Fair Value on a Nonrecurring Basis

In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a nonrecurring basis. These nonrecurring fair value measurements are considered to be Level 3 in the fair value hierarchy.

As further discussed in Note 4, "Held for Sale" during the fourth quarter of fiscal year 2022, the Company met the criteria to recognize the Russian business as held for sale which resulted in the Company remeasuring the disposal group at its fair value, less cost to sell, which is considered a Level 3 fair value ~~measurement.~~measurement and recognized an impairment charge of $90 million in the quarter ended June 30, 2022. In establishing the fair value, less cost to sell, as of June 30, 2022, management evaluated pre-diligence offers received and discounted them after considering various uncertainties present at the time, including evolving customer decisions on remaining in the region and decisions to move business out of the region. In addition, management consulted with an external advisor to assess the discount that the Russian government was likely to apply to the transaction value given the newly introduced requirement to obtain approval of the transaction and agreed purchase consideration from a Russian government commission prior to the sale. The Company completed the disposal of its Russian business in the second quarter of fiscal year 2023 and as of ~~December~~March 31, ~~2022,~~2023, the Company's other assets and liabilities held for sale are immaterial. Refer to Note 4, "Held for Sale" for further information.

~~Following a commitment to sell~~Resulting from the disposal of non-core assets during the ~~three and six~~nine months ended ~~December~~March 31, ~~2021,~~2022, the

Company has recorded an expense of $9 million, predominantly to adjust the long-lived assets to their fair value less cost to sell

as determined in reference to the selling price in the signed sale and purchase agreement. During the ~~six~~nine months ended ~~December~~March 31, ~~2021, long-lived~~2022, long-

lived assets with a carrying value of $12 million were written down to a fair value of zero as the Company's Durban, South Africa, manufacturing facility was destroyed in a fire as the result of general civil unrest. In addition, other long-lived assets in South Africa, with a carrying amount of $8 million, were written down to their estimated fair value of $4 million using ~~level~~Level 3 inputs. These expenses are included within other ~~income,~~income/(expenses), net in the accompanying unaudited condensed consolidated statements of income.

The Company tests indefinite-lived intangibles, including goodwill, for impairment when facts and circumstances indicate the carrying value may not be recoverable. These nonrecurring fair value measurements are considered to be Level 3 in the fair value hierarchy. During the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, and ~~2021,~~2022, there were no impairment charges recorded on indefinite-lived intangibles, including goodwill.

Note 9 - Derivative Instruments

The Company periodically uses derivatives and other financial instruments to hedge exposures to interest rate, commodity price, and currency risks. The Company does not hold or issue derivative instruments for speculative or trading purposes. For hedges that meet the hedge accounting criteria, the Company, at inception, formally designates and documents the instruments as a fair value hedge or a cash flow hedge of a specific underlying exposure. On an ongoing basis, the Company assesses and documents that its hedges have been and are expected to continue to be highly effective.

Interest Rate Risk

The Company's policy is to manage exposure to interest rate risk by maintaining a mixture of fixed-rate and variable-rate debt, monitoring global interest rates, and, where appropriate, hedging floating interest rate exposure or debt at fixed interest rates through various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, and interest rate locks. For interest rate swaps that are accounted for as fair value hedges, the gains and losses related to the changes in the fair value of the interest rate swaps are included in interest expense and offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. Changes in the fair value of interest rate swaps that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income in other ~~income,~~income/(expenses), net.

During the quarter ended December 31, 2022, the Company entered into interest rate swap contracts for a total notional amount of $1.25 billion. Under the terms of the contracts, the Company pays a weighted-average fixed rate of interest of 4.53% and receives a variable rate of interest, based on compound overnight SOFR, for the period from November 2022 through June 2023, settled monthly. During the quarter ended March 31, 2023, the Company entered into interest rate swap contracts for a total notional amount of $1.2 billion. Under the terms of the contracts, the Company pays a weighted-average fixed interest rate of 3.88% and receives a variable rate of interest, based on 1-month Term SOFR, from July 2023 through June 2024, settled monthly. As of ~~December~~March 31, ~~2022, and~~2023, the Company had no other receive-variable/pay-fixed interest rate swaps than those listed above. As of June 30, 2022, the ~~total notional amounts of such~~Company had no receive-variable/pay-fixed interest rate ~~swaps were $1.25 billion and zero, respectively.~~swaps. Although the Company is not applying hedge accounting, the Company believes that these economic hedging instruments are effective in protecting the Company against the risks of changes in the variable interest rate on a portion of its forecasted commercial paper issuances.

As of ~~December~~March 31, ~~2022,~~2023, and June 30, 2022, the total notional amount of the Company’s receive-fixed/pay-variable interest rate swaps accounted for as fair value hedges of certain of the Company's term debt was $650 million.

Foreign Currency Risk

The Company manufactures and sells its products and finances its operations in a number of countries throughout the world and, as a result, is exposed to movements in foreign currency exchange rates. The purpose of the Company's foreign currency hedging program is to manage the volatility associated with the changes in exchange rates.

To manage this exchange rate risk, the Company utilizes forward contracts. Contracts that qualify for hedge accounting are designated as cash flow hedges of certain forecasted transactions denominated in foreign currencies. The effective portion of the changes in fair value of these instruments is reported in accumulated other comprehensive loss ("AOCI") and reclassified into earnings in the same financial statement line item and in the same period or periods during which the related hedged transactions affect earnings. The ineffective portion is recognized in earnings over the life of the hedging relationship in the same consolidated statements of income line item as the underlying hedged item. Changes in the fair value of forward contracts that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income.

As of ~~December~~March 31, ~~2022,~~2023, and June 30, 2022, the notional amount of the outstanding forward contracts was ~~$1.1~~$0.8 billion and $1.0 billion, respectively.

Commodity Risk

Certain raw materials used in the Company's production processes are subject to price volatility caused by weather, supply conditions, political and economic variables, and other unpredictable factors. The Company's policy is to minimize exposure to price volatility by passing through the commodity price risk to customers, including the use of fixed price swaps.

In some cases, the Company purchases, on behalf of customers, fixed price commodity swaps to offset the exposure of price volatility on the underlying sales contracts. These instruments are cash closed out on maturity and the related cost or benefit is passed through to customers. Information about commodity price exposure is derived from supply forecasts submitted by customers

and these exposures are hedged by central treasury units. Changes in the fair value of commodity hedges are

recognized in AOCI. The cumulative amount of the hedge is recognized in the unaudited condensed consolidated statements of income when the forecasted transaction is realized.

The Company had the following outstanding commodity contracts to hedge forecasted purchases:

~~December~~March 31, ~~2022~~2023

June 30, 2022

Commodity

Volume

Aluminum

~~16,080~~13,541 tons

17,040 tons

PET resin

~~1,800,000~~— lbs.

16,886,520 lbs.

The following table provides the location of derivative instruments in the unaudited condensed consolidated balance sheets:


($ in millions)	($ in millions)	Balance Sheet Location	December 31, 2022		June 30, 2022		($ in millions)	Balance Sheet Location	March 31, 2023		June 30, 2022
Assets	Assets						Assets
Derivatives in cash flow hedging relationships:	Derivatives in cash flow hedging relationships:						Derivatives in cash flow hedging relationships:
Commodity contracts	Commodity contracts	Other current assets	$	1	$	6	Commodity contracts	Other current assets	$	—	$	6
Forward exchange contracts	Forward exchange contracts	Other current assets	4		3		Forward exchange contracts	Other current assets	3		3
Forward exchange contracts	Forward exchange contracts	Assets held for sale, net	—		3		Forward exchange contracts	Assets held for sale, net	—		3

Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:						Derivatives not designated as hedging instruments:
Forward exchange contracts	Forward exchange contracts	Other current assets	4		1		Forward exchange contracts	Other current assets	5		1
Interest rate swaps	Interest rate swaps	Other current assets	1		—		Interest rate swaps	Other current assets	7		—
Total current derivative contracts	Total current derivative contracts		10		13		Total current derivative contracts		15		13

Total non-current derivative contracts	Total non-current derivative contracts		—		—		Total non-current derivative contracts		—		—
Total derivative asset contracts	Total derivative asset contracts		$	10	$	13	Total derivative asset contracts		$	15	$	13

Liabilities	Liabilities						Liabilities
Derivatives in cash flow hedging relationships:	Derivatives in cash flow hedging relationships:						Derivatives in cash flow hedging relationships:
Commodity contracts	Commodity contracts	Other current liabilities	$	1	$	3	Commodity contracts	Other current liabilities	$	1	$	3
Forward exchange contracts	Forward exchange contracts	Other current liabilities	3		5		Forward exchange contracts	Other current liabilities	2		5

Derivatives not designated as hedging instruments:	Derivatives not designated as hedging instruments:						Derivatives not designated as hedging instruments:
Forward exchange contracts	Forward exchange contracts	Other current liabilities	7		11		Forward exchange contracts	Other current liabilities	1		11

Total current derivative contracts	Total current derivative contracts		11		19		Total current derivative contracts		4		19
Derivatives in cash flow hedging relationships:	Derivatives in cash flow hedging relationships:						Derivatives in cash flow hedging relationships:
Forward exchange contracts	Forward exchange contracts	Other non-current liabilities	1		1		Forward exchange contracts	Other non-current liabilities	—		1
Derivatives in fair value hedging relationships:	Derivatives in fair value hedging relationships:						Derivatives in fair value hedging relationships:
Interest rate swaps	Interest rate swaps	Other non-current liabilities	97		69		Interest rate swaps	Other non-current liabilities	83		69

Total non-current derivative contracts	Total non-current derivative contracts		98		70		Total non-current derivative contracts		83		70
Total derivative liability contracts	Total derivative liability contracts		$	109	$	89	Total derivative liability contracts		$	87	$	89

Certain derivative financial instruments are subject to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments within the unaudited condensed consolidated balance sheets.

The following tables provide the effects of derivative instruments on AOCI and in the unaudited condensed consolidated statements of income:


		Location of Gain / (Loss) Reclassified from AOCI into Income (Effective Portion)		Gain / (Loss) Reclassified from AOCI into Income (Effective Portion)																	Location of Gain / (Loss) Reclassified from AOCI into Income (Effective Portion)		Gain / (Loss) Reclassified from AOCI into Income (Effective Portion)
			Three Months Ended December 31,							Six Months Ended December 31,												Three Months Ended March 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)		2022			2021				2022				2021		($ in millions)						2023			2022				2023				2022
Derivatives in cash flow hedging relationships	Derivatives in cash flow hedging relationships																			Derivatives in cash flow hedging relationships
Commodity contracts	Commodity contracts		Cost of sales			$	(4)			$	6			$	(2)			$	12	Commodity contracts		Cost of sales			$	4			$	3			$	2			$	15
Forward exchange contracts	Forward exchange contracts	Net sales		(1)				—				(1)				—		Forward exchange contracts			Net sales		(1)				1				(2)				1

Treasury locks	Treasury locks	Interest expense		—				—				(1)				(1)		Treasury locks			Interest expense		(1)				(1)				(2)				(2)
Total	Total			$	(5)			$	6			$	(4)			$	11	Total					$	2			$	3			$	(2)			$	14


		Location of Gain / (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income		Gain / (Loss) Recognized in Income for Derivatives Not Designated as Hedging Instruments																	Location of Gain / (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income		Gain / (Loss) Recognized in Income for Derivatives Not Designated as Hedging Instruments
			Three Months Ended December 31,							Six Months Ended December 31,												Three Months Ended March 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)		2022			2021				2022				2021		($ in millions)						2023			2022				2023				2022
Derivatives not designated as hedging instruments	Derivatives not designated as hedging instruments																			Derivatives not designated as hedging instruments
Forward exchange contracts	Forward exchange contracts		Other income, net			$	10			$	(20)			$	(5)			$	(33)	Forward exchange contracts		Other income/(expenses), net			$	(7)			$	(9)			$	(12)			$	(42)
Interest rate swaps	Interest rate swaps	Other income, net		1				—				1				—		Interest rate swaps			Other income/(expenses), net		6				—				7				—
Total	Total			$	11			$	(20)			$	(4)			$	(33)	Total					$	(1)			$	(9)			$	(5)			$	(42)


		Location of Gain (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income		Gain (Loss) Recognized in Income for Derivatives in Fair Value Hedging Relationships																	Location of Gain (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income		Gain (Loss) Recognized in Income for Derivatives in Fair Value Hedging Relationships
			Three Months Ended December 31,							Six Months Ended December 31,												Three Months Ended March 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)		2022			2021				2022				2021		($ in millions)						2023			2022				2023				2022
Derivatives in fair value hedging relationships	Derivatives in fair value hedging relationships																			Derivatives in fair value hedging relationships
Interest rate swaps	Interest rate swaps		Interest expense			$	5			$	(3)			$	(28)			$	(7)	Interest rate swaps		Interest expense			$	15			$	(42)			$	(13)			$	(49)

Forward exchange contracts																		Forward exchange contracts			Other income/(expense), net		—				(12)				—				(12)
Total	Total			$	5			$	(3)			$	(28)			$	(7)	Total					$	15			$	(54)			$	(13)			$	(61)

Note 10 - Components of Net Periodic Benefit Cost

Net periodic benefit cost for benefit plans included the following components:


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		2022		2021		($ in millions)	2023		2022		2023		2022
Service cost	Service cost	$	5	$	6	$	9	$	12	Service cost	$	4	$	6	$	13	$	18
Interest cost	Interest cost	12		10		24		21		Interest cost	12		9		36		30
Expected return on plan assets	Expected return on plan assets	(14)		(17)		(28)		(33)		Expected return on plan assets	(14)		(14)		(42)		(47)
Amortization of actuarial loss	Amortization of actuarial loss	—		2		1		3		Amortization of actuarial loss	1		1		2		4
Amortization of prior service credit	Amortization of prior service credit	(1)		(1)		(2)		(2)		Amortization of prior service credit	(1)		(1)		(3)		(3)

Settlement costs	Settlement costs	—		3		—		3		Settlement costs	—		—		—		3
Net periodic benefit cost	Net periodic benefit cost	$	2	$	3	$	4	$	4	Net periodic benefit cost	$	2	$	1	$	6	$	5

Service cost is included in operating income. All other components of net periodic benefit cost other than service cost are recorded within other non-operating income, net.

On October 12, 2021, the Company contracted with Pacific Life Insurance Company to purchase a group annuity contract and to transfer $186 million of its pension plan assets and related benefit obligations. This transaction required a remeasurement of the pension plan assets and obligations and resulted in the recognition of a $3 million non-cash pension settlement loss in the ~~three and six~~nine months ended ~~December~~March 31, ~~2021.~~2022.

Note 11 - Debt

On March 22, 2023, the Company redeemed Euro bonds of a principal amount of €300 million (equivalent to $322 million) at maturity. The redemption was funded with commercial paper. The notes carried an interest rate of 2.75%.

As set forth in Note 9, "Derivative Instruments", during the quarter ended December 31, 2022, the Company entered into interest rate swap contracts for a total notional amount of $1.25 billion. During the quarter ended March 31, 2023, the Company entered into two additional interest rate swap contracts for a total notional amount of $1.2 billion.

Note 12 - Income Taxes

The provision for income taxes for the three and ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022, is based on the Company’s estimated annual effective tax rate for the respective fiscal years, and is applied on income before income taxes, and adjusted for specific items that are required to be recognized in the period in which they are incurred.

The effective tax rate for the three months ended ~~December~~March 31, ~~2022~~2023 decreased by ~~14.3~~5.0 percentage points compared to the three months ended ~~December~~March 31, ~~2021~~2022 from 21.0% to ~~6.7%~~16.0%, primarily due to differences in the income mix ~~including higher non-taxable income in the current period,~~ and ~~the difference in magnitude of~~ discrete ~~events in both periods.~~events.

The effective tax rate for the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 decreased by ~~10.7~~9.3 percentage points compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 from ~~22.3%~~21.8% to ~~11.6%~~12.5%, primarily due to the non-taxable gain on the sale of the Russian business, differences in the income mix ~~including higher non-taxable income in the current period,~~ and ~~the differences in the magnitude of~~ discrete ~~events in both periods.~~events.

2425

Note 1213 - Shareholders' Equity

The changes in ordinary and treasury shares during the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022 were as follows:


		Ordinary Shares			Treasury Shares				Ordinary Shares			Treasury Shares
(shares and $ in millions)	(shares and $ in millions)	Number of Shares	Amount		Number of Shares	Amount		(shares and $ in millions)	Number of Shares	Amount		Number of Shares	Amount
Balance as of June 30, 2021	Balance as of June 30, 2021	1,538	$	15	3	$	(29)	Balance as of June 30, 2021	1,538	$	15	3	$	(29)
Share buy-back / cancellations	Share buy-back / cancellations	(25)	—		—	—		Share buy-back / cancellations	(36)	—		—	—
Options exercised and shares vested	Options exercised and shares vested	—	—		(11)	125		Options exercised and shares vested	—	—		(11)	127

Purchase of treasury shares	Purchase of treasury shares	—	—		11	(133)		Purchase of treasury shares	—	—		11	(133)
Balance as of December 31, 2021		1,513	$	15	3	$	(37)
Balance as of March 31, 2022								Balance as of March 31, 2022	1,503	$	15	3	$	(35)

Balance as of June 30, 2022	Balance as of June 30, 2022	1,489	$	15	2	$	(18)	Balance as of June 30, 2022	1,489	$	15	2	$	(18)
Share buyback / cancellations	Share buyback / cancellations	(3)	—		—	—		Share buyback / cancellations	(18)	—		—	—
Options exercised and shares vested	Options exercised and shares vested	—	—		(18)	221		Options exercised and shares vested	—	—		(19)	225

Purchase of treasury shares	Purchase of treasury shares	—	—		18	(221)		Purchase of treasury shares	—	—		18	(221)
Balance as of December 31, 2022		1,486	$	15	2	$	(18)
Balance as of March 31, 2023								Balance as of March 31, 2023	1,471	$	15	1	$	(14)

The changes in the components of accumulated other comprehensive loss during the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022 were as follows:


		Foreign Currency Translation		Net Investment Hedge		Pension		Effective Derivatives		Total Accumulated Other Comprehensive Loss			Foreign Currency Translation		Net Investment Hedge		Pension		Effective Derivatives		Total Accumulated Other Comprehensive Loss
($ in millions)	($ in millions)	(Net of Tax)		(Net of Tax)		(Net of Tax)		(Net of Tax)				($ in millions)	(Net of Tax)		(Net of Tax)		(Net of Tax)		(Net of Tax)
Balance as of June 30, 2021	Balance as of June 30, 2021	$	(691)	$	(13)	$	(54)	$	(8)	$	(766)	Balance as of June 30, 2021	$	(691)	$	(13)	$	(54)	$	(8)	$	(766)
Other comprehensive income / (loss) before reclassifications	Other comprehensive income / (loss) before reclassifications	(115)		—		(1)		2		(114)		Other comprehensive income / (loss) before reclassifications	(41)		—		(1)		8		(34)
Amounts reclassified from accumulated other comprehensive loss	Amounts reclassified from accumulated other comprehensive loss	—		—		4		(9)		(5)		Amounts reclassified from accumulated other comprehensive loss	—		—		4		(11)		(7)
Net current period other comprehensive income / (loss)	Net current period other comprehensive income / (loss)	(115)		—		3		(7)		(119)		Net current period other comprehensive income / (loss)	(41)		—		3		(3)		(41)
Balance as of December 31, 2021		$	(806)	$	(13)	$	(51)	$	(15)	$	(885)
Balance as of March 31, 2022												Balance as of March 31, 2022	$	(732)	$	(13)	$	(51)	$	(11)	$	(807)

Balance as of June 30, 2022	Balance as of June 30, 2022	$	(892)	$	(13)	$	40	$	(15)	$	(880)	Balance as of June 30, 2022	$	(892)	$	(13)	$	40	$	(15)	$	(880)
Other comprehensive loss before reclassifications	Other comprehensive loss before reclassifications	(91)		—		—		(6)		(97)		Other comprehensive loss before reclassifications	(48)		—		(1)		(2)		(51)
Amounts reclassified from accumulated other comprehensive loss	Amounts reclassified from accumulated other comprehensive loss	74		—		(1)		3		76		Amounts reclassified from accumulated other comprehensive loss	74		—		(1)		1		74
Net current period other comprehensive loss		(17)		—		(1)		(3)		(21)
Balance as of December 31, 2022		$	(909)	$	(13)	$	39	$	(18)	$	(901)
Net current period other comprehensive income / (loss)												Net current period other comprehensive income / (loss)	26		—		(2)		(1)		23
Balance as of March 31, 2023												Balance as of March 31, 2023	$	(866)	$	(13)	$	38	$	(16)	$	(857)

2526

The following tables provide details of amounts reclassified from accumulated other comprehensive loss:


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		2022		2021		($ in millions)	2023		2022		2023		2022
Amortization of pension:	Amortization of pension:									Amortization of pension:
Amortization of prior service credit	Amortization of prior service credit	$	(1)	$	(1)	$	(2)	$	(2)	Amortization of prior service credit	$	(1)	$	(1)	$	(3)	$	(3)
Amortization of actuarial loss	Amortization of actuarial loss	—		2		1		3		Amortization of actuarial loss	1		1		2		4
Effect of pension settlement	Effect of pension settlement	—		3		—		3		Effect of pension settlement	—		—		—		3
Total before tax effect	Total before tax effect	(1)		4		(1)		4		Total before tax effect	—		—		(1)		4
Tax effect on amounts reclassified into earnings	Tax effect on amounts reclassified into earnings	—		—		—		—		Tax effect on amounts reclassified into earnings	—		—		—		—
Total net of tax	Total net of tax	$	(1)	$	4	$	(1)	$	4	Total net of tax	$	—	$	—	$	(1)	$	4

(Gains) / losses on cash flow hedges:	(Gains) / losses on cash flow hedges:									(Gains) / losses on cash flow hedges:
Commodity contracts	Commodity contracts	$	4	$	(6)	$	2	$	(12)	Commodity contracts	$	(4)	$	(3)	$	(2)	$	(15)
Forward exchange contracts	Forward exchange contracts	1		—		1		—		Forward exchange contracts	1		(1)		2		(1)
Treasury locks	Treasury locks	—		—		1		1		Treasury locks	1		1		2		2
Total before tax effect	Total before tax effect	5		(6)		4		(11)		Total before tax effect	(2)		(3)		2		(14)
Tax effect on amounts reclassified into earnings	Tax effect on amounts reclassified into earnings	(1)		1		(1)		2		Tax effect on amounts reclassified into earnings	—		1		(1)		3
Total net of tax	Total net of tax	$	4	$	(5)	$	3	$	(9)	Total net of tax	$	(2)	$	(2)	$	1	$	(11)

Losses on foreign currency translation:	Losses on foreign currency translation:									Losses on foreign currency translation:
Foreign currency translation adjustment	Foreign currency translation adjustment	$	74	$	—	$	74	$	—	Foreign currency translation adjustment	$	—	$	—	$	74	$	—
Total before tax effect	Total before tax effect	74		—		74		—		Total before tax effect	—		—		74		—
Tax effect on amounts reclassified into earnings	Tax effect on amounts reclassified into earnings	—		—		—		—		Tax effect on amounts reclassified into earnings	—		—		—		—
Total net of tax	Total net of tax	$	74	$	—	$	74	$	—	Total net of tax	$	—	$	—	$	74	$	—

Forward contracts to purchase own shares

The Company's employee share plans require the delivery of shares to employees in the future when rights vest or vested options are exercised. The Company currently acquires shares on the open market to deliver shares to employees to satisfy vesting or exercising commitments. This exposes the Company to market price risk.

To manage the market price risk, the Company has entered into forward contracts for the purchase of its ordinary shares. As of ~~December~~March 31, ~~2022,~~2023, the Company had forward contracts outstanding that mature between ~~March~~May 2023 and ~~May~~September 2023 to purchase 10 million shares at a weighted average price of $12.38. As of June 30, 2022, the Company had forward contracts outstanding ~~that mature~~maturing between November 2022 and June 2023 to purchase 14 million shares at a weighted average price of $12.67. During the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, forward contracts related to 11 million shares were settled, which were outstanding as of June 30, 2022.

The forward contracts to purchase the Company's own shares are classified as a current liability. Equity is reduced by an amount equal to the fair value of the shares at inception. The carrying value of the forward contracts at each reporting period was determined based on the present value of the cost required to settle the contracts.

2627

Note 1314 - Segments

The Company's business is organized and presented in the two reportable segments outlined below:

Flexibles: Consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Russian business results through the date of disposal are included in the Flexibles reportable segment.

Rigid Packaging: Consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads and personal care items, and plastic caps for a wide variety of applications.

Other consists of the Company's undistributed corporate expenses including executive and functional compensation costs, equity method and other investments, intercompany eliminations, and other business activities.

The accounting policies of the reportable segments are the same as those in the unaudited condensed consolidated financial statements. Intersegment sales and transfers are not significant.

2728

The following table presents information about reportable segments:


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		2022		2021		($ in millions)	2023		2022		2023		2022

Flexibles	Flexibles	$	2,812	$	2,713	$	5,591	$	5,347	Flexibles	$	2,787	$	2,837	$	8,378	$	8,184
Rigid Packaging	Rigid Packaging	830		794		1,763		1,580		Rigid Packaging	880		871		2,643		2,451
Other	Other	—		—		—		—		Other	—		—		—		—

Net sales	Net sales	$	3,642	$	3,507	$	7,354	$	6,927	Net sales	$	3,667	$	3,708	$	11,021	$	10,635

Adjusted earnings before interest and taxes ("Adjusted EBIT")	Adjusted earnings before interest and taxes ("Adjusted EBIT")									Adjusted earnings before interest and taxes ("Adjusted EBIT")
Flexibles	Flexibles	$	353	$	352	$	706	$	691	Flexibles	$	337	$	378	$	1,043	$	1,069
Rigid Packaging	Rigid Packaging	57		55		123		117		Rigid Packaging	69		77		192		194
Other	Other	(11)		(19)		(38)		(39)		Other	(24)		(28)		(62)		(67)
Adjusted EBIT	Adjusted EBIT	399		388		791		769		Adjusted EBIT	382		427		1,173		1,196
Less: Material restructuring programs (1)		—		(10)		—		(17)
Less: 2019 Bemis Integration Plan										Less: 2019 Bemis Integration Plan	—		(9)		—		(26)

Less: Amortization of acquired intangible assets from business combinations ~~(2)~~(1)	Less: Amortization of acquired intangible assets from business combinations ~~(2)~~(1)	(40)		(41)		(80)		(82)		Less: Amortization of acquired intangible assets from business combinations ~~(2)~~(1)	(40)		(40)		(120)		(122)

Less: Impact of hyperinflation ~~(3)~~(2)	Less: Impact of hyperinflation ~~(3)~~(2)	(5)		(2)		(13)		(4)		Less: Impact of hyperinflation ~~(3)~~(2)	(6)		(6)		(19)		(10)
Less: Net loss on disposals ~~(4)~~(3)	Less: Net loss on disposals ~~(4)~~(3)	—		(9)		—		(9)		Less: Net loss on disposals ~~(4)~~(3)	—		—		—		(9)
Add/(Less): Property and other gains/(losses), net ~~(5)~~(4)	Add/(Less): Property and other gains/(losses), net ~~(5)~~(4)	—		1		—		(27)		Add/(Less): Property and other gains/(losses), net ~~(5)~~(4)	—		4		—		(23)
Less: Pension settlement ~~(6)~~(5)	Less: Pension settlement ~~(6)~~(5)	—		(3)		—		(3)		Less: Pension settlement ~~(6)~~(5)	—		—		—		(3)
Add: Russia-Ukraine conflict impacts (7)		207		—		204		—
Add/(Less): Other (8)		1		—		2		(2)
Add/(Less): Russia-Ukraine conflict impacts (6)										Add/(Less): Russia-Ukraine conflict impacts (6)	(48)		—		156		—
Less: Other (7)										Less: Other (7)	(4)		(2)		(2)		(4)

Interest income	Interest income	11		5		20		10		Interest income	15		5		35		15
Interest expense	Interest expense	(79)		(39)		(138)		(79)		Interest expense	(86)		(36)		(224)		(115)

Income before income taxes	Income before income taxes	$	494	$	290	$	786	$	556	Income before income taxes	$	213	$	343	$	999	$	899

(1)~~Material restructuring programs includes restructuring and related expenses for the 2019 Bemis Integration Plan for the three and six months ended December 31, 2021.~~

~~(2)~~Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from past acquisitions.

~~(3)~~(2)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.

~~(4)~~(3)Net loss on disposals for the ~~three and six~~nine months ended ~~December~~March 31, ~~2021~~2022 includes an expense of $9 million ~~triggered by a commitment to sell~~from the disposal of non-core assets. Refer to Note 8, "Fair Value Measurements" for more information.

~~(5)~~(4)Property and other gains/(losses), net includes property and related business losses primarily associated with the destruction of the Company's Durban, South Africa facility during general civil unrest in July 2021, net of insurance recovery.

~~(6)~~(5)Pension settlement for the ~~three and six~~nine months ended ~~December~~March 31, ~~2021~~2022 relates to the purchase of a group annuity contract and transfer of pension plan assets and related benefit obligations. Refer to Note 10, "Components of Net Periodic Benefit Cost" for more information.

~~(7)~~(6)Russia-Ukraine conflict impacts in the ~~three and six~~nine months ended ~~December~~March 31, ~~2022~~2023 include a pre-tax net gain on sale of Russian business of $215 million (refer to Note 3, "Restructuring and Other Related Activities, Net"), and incremental costs and restructuring incurred in connection with the ~~conflict and restructuring.~~conflict.

~~(8)~~(7)Other includes restructuring expenses and fair value ~~movements~~gains on economic hedges in the three and ~~six~~nine months ended ~~December~~March 31, ~~2022.~~2023. For the three and nine months ended March 31, 2022, Other includes costs associated with the Bemis transaction.

2829

The following tables disaggregate net sales, excluding intersegment sales, by geography in which the Company operates based on manufacturing or selling operations:


		Three Months Ended December 31,													Three Months Ended March 31,
		2022						2021							2023						2022
($ in millions)	($ in millions)	Flexibles		Rigid Packaging		Total		Flexibles		Rigid Packaging		Total		($ in millions)	Flexibles		Rigid Packaging		Total		Flexibles		Rigid Packaging		Total
North America	North America	$	1,092	$	623	$	1,715	$	1,030	$	609	$	1,639	North America	$	1,129	$	688	$	1,817	$	1,103	$	677	$	1,780
Latin America	Latin America	269		207		476		251		185		436		Latin America	271		192		463		262		194		456
Europe	Europe	1,030		—		1,030		985		—		985		Europe	985		—		985		1,049		—		1,049
Asia Pacific	Asia Pacific	421		—		421		447		—		447		Asia Pacific	402		—		402		423		—		423
Net sales	Net sales	$	2,812	$	830	$	3,642	$	2,713	$	794	$	3,507	Net sales	$	2,787	$	880	$	3,667	$	2,837	$	871	$	3,708

		Six Months Ended December 31,													Nine Months Ended March 31,
		2022						2021							2023						2022
($ in millions)	($ in millions)	Flexibles		Rigid Packaging		Total		Flexibles		Rigid Packaging		Total		($ in millions)	Flexibles		Rigid Packaging		Total		Flexibles		Rigid Packaging		Total
North America	North America	$	2,198	$	1,349	$	3,547	$	2,049	$	1,238	$	3,287	North America	$	3,327	$	2,037	$	5,364	$	3,152	$	1,915	$	5,067
Latin America	Latin America	554		414		968		507		342		849		Latin America	825		606		1,431		769		536		1,305
Europe	Europe	1,985		—		1,985		1,923		—		1,923		Europe	2,970		—		2,970		2,972		—		2,972
Asia Pacific	Asia Pacific	854		—		854		868		—		868		Asia Pacific	1,256		—		1,256		1,291		—		1,291
Net sales	Net sales	$	5,591	$	1,763	$	7,354	$	5,347	$	1,580	$	6,927	Net sales	$	8,378	$	2,643	$	11,021	$	8,184	$	2,451	$	10,635

2930

Note 1415 - Earnings Per Share Computations

The Company applies the two-class method when computing its earnings per share ("EPS"), which requires that net income per share for each class of share be calculated assuming all of the Company's net income is distributed as dividends to each class of share based on their contractual rights.

Basic EPS is computed by dividing net income available to ordinary shareholders by the weighted-average number of ordinary shares outstanding after excluding the ordinary shares to be repurchased using forward contracts. Diluted EPS includes the effects of share options, restricted shares, performance rights, performance shares, and share rights, if dilutive.


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
(in millions, except per share amounts)	(in millions, except per share amounts)	2022		2021		2022		2021		(in millions, except per share amounts)	2023		2022		2023		2022
Numerator	Numerator									Numerator
Net income attributable to Amcor plc	Net income attributable to Amcor plc	$	459	$	225	$	691	$	427	Net income attributable to Amcor plc	$	177	$	269	$	868	$	696
Distributed and undistributed earnings attributable to shares to be repurchased	Distributed and undistributed earnings attributable to shares to be repurchased	(3)		(1)		(6)		(1)		Distributed and undistributed earnings attributable to shares to be repurchased	(1)		(1)		(6)		(2)
Net income available to ordinary shareholders of Amcor plc—basic and diluted	Net income available to ordinary shareholders of Amcor plc—basic and diluted	$	456	$	224	$	685	$	426	Net income available to ordinary shareholders of Amcor plc—basic and diluted	$	176	$	268	$	862	$	694

Denominator	Denominator									Denominator
Weighted-average ordinary shares outstanding	Weighted-average ordinary shares outstanding	1,486		1,523		1,485		1,528		Weighted-average ordinary shares outstanding	1,480		1,506		1,484		1,521
Weighted-average ordinary shares to be repurchased by Amcor plc	Weighted-average ordinary shares to be repurchased by Amcor plc	(11)		(3)		(11)		(4)		Weighted-average ordinary shares to be repurchased by Amcor plc	(10)		(3)		(11)		(4)
Weighted-average ordinary shares outstanding for EPS—basic	Weighted-average ordinary shares outstanding for EPS—basic	1,475		1,520		1,474		1,524		Weighted-average ordinary shares outstanding for EPS—basic	1,470		1,503		1,473		1,517
Effect of dilutive shares	Effect of dilutive shares	10		4		11		4		Effect of dilutive shares	6		4		9		4
Weighted-average ordinary shares outstanding for EPS—diluted	Weighted-average ordinary shares outstanding for EPS—diluted	1,485		1,524		1,486		1,528		Weighted-average ordinary shares outstanding for EPS—diluted	1,476		1,507		1,482		1,521

Per ordinary share income	Per ordinary share income									Per ordinary share income

Basic earnings per ordinary share	Basic earnings per ordinary share	$	0.309	$	0.148	$	0.465	$	0.280	Basic earnings per ordinary share	$	0.120	$	0.178	$	0.585	$	0.457

Diluted earnings per ordinary share	Diluted earnings per ordinary share	$	0.307	$	0.148	$	0.461	$	0.279	Diluted earnings per ordinary share	$	0.119	$	0.178	$	0.581	$	0.456

Note: Per share amounts are computed independently for each of the quarters presented. The sum of the quarters may not equal the total year amount due to the impact of changes in average quarterly shares outstanding and all other quarterly amounts may not equal the total year due to rounding.

Certain outstanding share options were excluded from the diluted earnings per share calculation because they were anti-dilutive. The excluded share options for the three and ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 represented an aggregate of 15 million and 1213 million shares, respectively. The excluded share options for the three and ~~six~~nine months ended ~~December~~March 31, ~~2021~~2022 represented an aggregate of 9 million and 56 million shares, respectively.

3031

Note 1516 - Contingencies and Legal Proceedings

Contingencies - Brazil

The Company's operations in Brazil are involved in various governmental assessments and litigation, principally related to claims for excise and income taxes. The Company vigorously defends its positions and believes it will prevail on most, if not all, of these matters. The Company does not believe that the ultimate resolution of these matters will materially impact the Company's consolidated results of operations, financial position, or cash flows. Under customary local regulations, the Company's Brazilian subsidiaries may need to post cash or other collateral if a challenge to any administrative assessment proceeds to the Brazilian court system; however, the level of cash or collateral already pledged or potentially required to be pledged would not significantly impact the Company's liquidity. ~~At December~~As of March 31, ~~2022,~~2023, the Company had recorded accruals of $1213 million, included in other non-current liabilities. The Company has estimated a reasonably possible loss exposure in excess of the accrual of ~~$21~~$22 million atas of ~~December~~March 31, ~~2022.~~2023. The litigation process is subject to many uncertainties and the outcome of individual matters cannot be accurately predicted. The Company routinely assesses these matters as to the probability of ultimately incurring a liability and records the best estimate of the ultimate loss in situations where the likelihood of an ultimate loss is probable. The Company's assessments are based on its knowledge and experience, but the ultimate outcome of any of these matters may differ from the Company's estimates.

As of ~~December~~March 31, ~~2022,~~2023, the Company has provided letters of credit of ~~$37~~$39 million, judicial insurance of $1 million, and deposited cash of ~~$12~~$13 million with the courts to continue to defend the cases.

Contingencies - Environmental Matters

The Company, along with others, has been identified as a potentially responsible party ("PRP") at several waste disposal sites under U.S. federal and related state environmental statutes and regulations and may face potentially material environmental remediation obligations. While the Company benefits from various forms of insurance policies, actual coverage may not, or only partially, cover the total potential exposures. ~~At December~~As of March 31, ~~2022, t~~he2023, the Company has recorded $17 million of aggregate accruals for its share of estimated future remediation costs at these sites.

In addition to the matters described above, at ~~December~~as of March 31, ~~2022,~~ 2023, the Company has also recorded aggregate accruals of $42 million for potential liabilities for remediation obligations at various worldwide locations that are owned or operated by the Company, or were formerly owned or operated.

The SEC requires the Company to disclose certain information about proceedings arising under federal, state, or local environmental provisions if the Company reasonably believes that such proceedings may result in monetary sanctions above a stated threshold. The Company uses a threshold of $1 million or more for purposes of determining whether disclosure of any such proceedings is required. Applying this threshold, there are no environmental matters required to be disclosed for the three and ~~six~~nine months ended ~~December~~March 31, ~~2022.~~2023.

While the Company believes that its accruals are adequate to cover its future obligations, there can be no assurance that the ultimate payments will not exceed the accrued amounts. Nevertheless, based on the available information, the Company does not believe that its potential environmental obligations will have a material adverse effect upon its liquidity, results of operations, or financial condition.

Other Matters

In the normal course of business, the Company is subject to legal proceedings, lawsuits, and other claims. While the potential financial impact with respect to these ordinary course matters is subject to many factors and uncertainties, management believes that any financial impact to the Company from these matters, individually and in the aggregate, would not have a material adverse effect upon its liquidity, results of operations, or financial condition.

3132

Note 1617 - Subsequent Events

On ~~January 16,~~April 28, 2023, the Company ~~announced it had entered into~~signed an agreement to acquire a ~~medical device~~manufacturer of high-performance modular vacuum packaging ~~company~~equipment for the fresh meat, poultry, and dairy markets, based in ~~Shanghai, China, which generates annual sales of approximately $50 million. The~~New Zealand. This acquisition ~~is subject to customary regulatory approvals~~will complement the Company’s existing strength in film and ~~is expected to close by the end of the third quarter of fiscal year 2023.~~enable a total system solution for automated protein packaging.

On ~~February 7,~~May 2, 2023, the Company's Board of Directors declared a quarterly cash dividend of $0.1225 per share to be paid on ~~March 21,~~June 20, 2023 to shareholders of record as of ~~March 1,~~May 24, 2023. Amcor has received a waiver from the Australian Securities Exchange ("ASX") settlement operating rules, which will allow Amcor to defer processing conversions between ordinary share and CHESS Depositary Instrument ("CDI") registers from ~~February 28,~~May 23, 2023 to ~~March 1,~~May 24, 2023, inclusive.

On February 7, 2023, the Company's Board of Directors approved a buyback of up to $100 million of ordinary shares and/or CHESS Depositary Instruments ("CDIs") in the following twelve months. Pursuant to this program, purchases of the Company's ordinary shares and/or CDIs will be made subject to market conditions and at prevailing market prices, through open market purchases. The Company is authorized to complete the share buyback within twelve months, however; the timing, volume, and nature of repurchase may be amended, suspended, or discontinued at any time.

On February 7, 2023, the Company's Board of Directors approved investing $110 million to $130 million of the cash received from the sale of the Company's Russian business in a range of additional initiatives to partly offset divested earnings.

3233

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis ("MD&A") should be read in conjunction with our Form 10-K for fiscal year 2022 filed with the U.S Securities and Exchange Commission (the "SEC") on August 18, 2022, together with the unaudited condensed consolidated financial statements and accompanying notes included in Part 1, Item 1 of this Form 10-Q. Throughout the MD&A, amounts and percentages may not recalculate due to rounding.

Summary of Financial Results


		Three Months Ended December 31,								Six Months Ended December 31,									Three Months Ended March 31,								Nine Months Ended March 31,
($ in millions)	($ in millions)	2022				2021				2022				2021				($ in millions)	2023				2022				2023				2022
Net sales	Net sales	$	3,642	100.0	%	$	3,507	100.0	%	$	7,354	100.0	%	$	6,927	100.0	%	Net sales	$	3,667	100.0	%	$	3,708	100.0	%	$	11,021	100.0	%	$	10,635	100.0	%
Cost of sales	Cost of sales	(2,980)		(81.8	%)	(2,862)		(81.6	%)	(6,024)		(81.9	%)	(5,632)		(81.3	%)	Cost of sales	(2,994)		(81.6	%)	(2,977)		(80.3	%)	(9,018)		(81.8	%)	(8,609)		(80.9	%)

Gross profit	Gross profit	662		18.2	%	645		18.4	%	1,330		18.1	%	1,295		18.7	%	Gross profit	673		18.4	%	731		19.7	%	2,003		18.2	%	2,026		19.1	%

Operating expenses:	Operating expenses:																	Operating expenses:
Selling, general, and administrative expenses	Selling, general, and administrative expenses	(298)		(8.2	%)	(303)		(8.6	%)	(600)		(8.2	%)	(616)		(8.9	%)	Selling, general, and administrative expenses	(317)		(8.6	%)	(326)		(8.8	%)	(917)		(8.3	%)	(942)		(8.9	%)
Research and development expenses	Research and development expenses	(24)		(0.7	%)	(23)		(0.7	%)	(49)		(0.7	%)	(48)		(0.7	%)	Research and development expenses	(27)		(0.7	%)	(24)		(0.6	%)	(76)		(0.7	%)	(72)		(0.7	%)
Restructuring and other related activities, net	Restructuring and other related activities, net	213		5.8	%	(10)		(0.3	%)	212		2.9	%	(18)		(0.3	%)	Restructuring and other related activities, net	(50)		(1.4	%)	(9)		(0.2	%)	162		1.5	%	(27)		(0.3	%)
Other income, net		6		0.2	%	13		0.4	%	8		0.1	%	5		0.1	%
Other income/(expenses), net																		Other income/(expenses), net	3		0.1	%	(3)		(0.1	%)	11		0.1	%	2		—	%

Operating income	Operating income	559		15.3	%	322		9.2	%	901		12.3	%	618		8.9	%	Operating income	282		7.7	%	369		10.0	%	1,183		10.7	%	987		9.3	%

Interest income	Interest income	11		0.3	%	5		0.1	%	20		0.3	%	10		0.1	%	Interest income	15		0.4	%	5		0.1	%	35		0.3	%	15		0.1	%
Interest expense	Interest expense	(79)		(2.2	%)	(39)		(1.1	%)	(138)		(1.9	%)	(79)		(1.1	%)	Interest expense	(86)		(2.3	%)	(36)		(1.0	%)	(224)		(2.0	%)	(115)		(1.1	%)
Other non-operating income, net	Other non-operating income, net	3		0.1	%	2		0.1	%	3		—	%	7		0.1	%	Other non-operating income, net	2		0.1	%	5		0.1	%	5		—	%	12		0.1	%

Income before income taxes	Income before income taxes	494		13.6	%	290		8.3	%	786		10.7	%	556		8.0	%	Income before income taxes	213		5.8	%	343		9.3	%	999		9.1	%	899		8.5	%

Income tax expense	Income tax expense	(33)		(0.9	%)	(61)		(1.7	%)	(91)		(1.2	%)	(124)		(1.8	%)	Income tax expense	(34)		(0.9	%)	(72)		(1.9	%)	(125)		(1.1	%)	(196)		(1.8	%)

Net income	Net income	$	461	12.7	%	$	229	6.5	%	$	695	9.5	%	$	432	6.2	%	Net income	$	179	4.9	%	$	271	7.3	%	$	874	7.9	%	$	703	6.6	%

Net income attributable to non-controlling interests	Net income attributable to non-controlling interests	(2)		(0.1	%)	(4)		(0.1	%)	(4)		(0.1	%)	(5)		(0.1	%)	Net income attributable to non-controlling interests	(2)		(0.1	%)	(2)		(0.1	%)	(6)		(0.1	%)	(7)		(0.1	%)

Net income attributable to Amcor plc	Net income attributable to Amcor plc	$	459	12.6	%	$	225	6.4	%	$	691	9.4	%	$	427	6.2	%	Net income attributable to Amcor plc	$	177	4.8	%	$	269	7.3	%	$	868	7.9	%	$	696	6.5	%

3334

Overview

Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and ~~personal-care,~~personal care, and other products. We work with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. We are focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. During fiscal year 2022, Amcor generated $14.5 billion in net sales.

Significant Items Affecting the Periods Presented

Raw Material, Inflation, and Supply Chain Trends

During ~~the first half of~~ fiscal year 2023, we have continued to experience intermittent supply shortages and price volatility of certain resins and raw materials as a result of market dynamics and higher rates of inflation impacting energy, fuel, and labor costs. In addition, higher inflation, especially in Europe and the United States, has led central banks to rapidly raise interest rates to dampen inflation which results in higher interest expense on our variable rate debt. The underlying causes for the continued volatility can be attributed to a variety of factors, including the ongoing regional impacts of the COVID-19 pandemic which has largely abated in the third quarter of fiscal year 2023, resulting in labor shortages and transportation constraints, energy shortages, and the ongoing impacts of macroeconomic and geopolitical conditions which are tied to the Russia-Ukraine conflict. We will continue to work closely with our suppliers and customers, leveraging our global capabilities and expertise to work through supply chain disruptions and other resulting issues. In addition, we are focused on driving costs out of our business in this challenging environment and recovering higher raw material costs to help mitigate inflation. However, there could be a time lag between recognizing the benefit of our mitigating actions and when the inflation occurs, and there is no assurance that our mitigating measures will be able to fully mitigate the impact of ongoing inflation.

Impact of COVID-19

We continue to monitor the impact of the ongoing 2019 Novel Coronavirus ("COVID-19") pandemic on all aspects of our business. The COVID-19 pandemic has resulted in intermittent regional government restrictions on the movement of people, goods, and non-essential services resulting in a period of historic uncertainty and challenges. We remain focused on our commitment to the health and safety of our employees as our first priority. We expect to continue to evaluate our response and related precautions until the COVID-19 pandemic has been fully resolved as a public health crisis.

There are currently no significant COVID-19 related restrictions on our business, with China relaxing controls and eliminating lockdowns in December 2022. Lockdowns inand related impacts, including the ~~first half~~unwinding of ~~fiscal year 2023 did impact~~lockdowns, has impacted demand for our products in China ~~and significant increases~~ in ~~COVID-19 infections~~fiscal year 2023 and may continue to impact demand for our products and lead to supply chain disruptions and other challenges. Throughout the COVID-19 pandemic, our facilities have largely been exempt from government mandated closure orders and while governmental measures may be modified, we expect that our facilities will remain operational given the essential products we supply. However, despite our best efforts to contain the impact in our facilities, it remains possible that significant disruptions could occur as a result of the pandemic, including temporary closures of our facilities due to outbreaks of the virus among our workforce or government mandates.

We continue to believe we are well-positioned to meet ~~the~~any continuing challenges of the ~~ongoing~~ COVID-19 pandemic and currently do not expect a material adverse impact on our business and financial results. However, the ultimate near-term impact of the pandemic on our business will depend on the extent and nature of any future disruptions across the supply chain, the implementation of further social distancing measures and other government-imposed restrictions, as well as the nature and pace of macroeconomic recovery in key global economies.

Russia and Ukraine Conflict / 2023 Restructuring Plan

Russia's invasion of Ukraine that began in February 2022 continues as of the date of the filing of this quarterly report. In advance of the invasion, we proactively suspended operations at our small manufacturing site in Ukraine. We also operated three manufacturing facilities in Russia ("Russian business") until their sale on December 23, 2022, for net cash proceeds of $365 million. In addition, ~~the Company~~we repatriated approximately $65 million in cash held in Russia as part of the transaction. ~~The~~We recorded a pre-tax net gain on sale of $215 ~~million includes the reversal~~million. The carrying value of ~~a pre-tax $90 million impairment charge taken in the fourth quarter of fiscal year 2022 to adjust~~ the Russian business ~~to its estimated fair value less cost to sell. We~~had previously been impaired by $90 million in the quarter ended June 30, 2022.

On February 7, 2023, we announced that we expect to invest $110 million to

~~$130~~ $130 million of the ~~cash received~~sale proceeds from the Russian business in ~~a range of additional~~various cost savings initiatives to partly offset divested ~~earnings.~~earnings from the Russian business (the "2023 Restructuring Plan" or the "Plan"). Of the remaining cash received, we plan to repurchase up to $100 million in additional shares and use the balance to reduce debt.

In the third quarter of fiscal year 2023, we initiated restructuring and related projects with an expected cost of approximately $95 million and approximately $50 million is expected to result in net ~~debt.~~cash expenditures. As part of this Plan, we have incurred $37 million in employee-related expenses, $1 million in fixed asset related expenses, $2 million in other restructuring expenses, and $2 million in restructuring related expenses. To date, the Plan has resulted in approximately $7 million in cash outflows. We expect approximately $17 million in cash outflows from projects initiated in the third fiscal quarter during the balance of fiscal year 2023. We continue to evaluate different options to offset divested earnings from the Russian business across our global footprint and expect to disclose the total program cost at the end of fiscal year 2023. Management expects to realize an annualized pre-tax benefit of approximately 30% per year on net cash employed in the Plan from structural cost reductions by the end of fiscal year 2025.

The conflict between Russia and Ukraine has negatively impacted the global economy and has the potential to result in continued supply chain disruptions and significant inflationary pressure on raw material prices and the cost and supply of other resources (such as energy and natural gas).

For further information, refer to Note 4, "Held for Sale," Note 5, "Acquisitions and Disposals," and " Note 6, "Restructuring," ~~and Note 16, "Subsequent Events"~~ of "Part I, Item 1, Notes to Condensed Consolidated Financial Statements."

Highly Inflationary Accounting

We have subsidiaries in Argentina that historically had a functional currency of the Argentine Peso. As of June 30, 2018, the Argentine economy has been designated as highly inflationary for accounting purposes. Accordingly, beginning July 1, 2018, we began reporting the financial results of our Argentine subsidiaries with a functional currency of the Argentine Peso at the functional currency of the parent, which is the U.S. dollar. Highly inflationary accounting in the three months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022 resulted in a negative impact of $5$6 million, and ~~$2 million, respectively, and $13~~$19 million and $4$10 million in the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, in foreign currency transaction losses that ~~was~~were reflected in the unaudited condensed consolidated statements of income.

3536

Results of Operations - Three Months Ended ~~December~~March 31, ~~2022~~2023

Consolidated Results of Operations


		Three Months Ended December 31,							Three Months Ended March 31,
($ in millions, except per share data)	($ in millions, except per share data)	2022			2021			($ in millions, except per share data)	2023			2022
Net sales	Net sales	$	3,642		$	3,507		Net sales	$	3,667		$	3,708
Operating income	Operating income	559			322			Operating income	282			369
Operating income as a percentage of net sales	Operating income as a percentage of net sales	15.3		%	9.2		%	Operating income as a percentage of net sales	7.7		%	10.0		%

Net income attributable to Amcor plc	Net income attributable to Amcor plc	$	459		$	225		Net income attributable to Amcor plc	$	177		$	269
Diluted Earnings Per Share	Diluted Earnings Per Share	$	0.307		$	0.148		Diluted Earnings Per Share	$	0.119		$	0.178

Net sales ~~increased~~decreased by ~~$135~~$41 million, or 4%1%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~2022. Excluding the pass-through of raw material costs of ~~$271~~$81 million, negative currency impacts of ~~$163~~$67 million, and negative impact of acquisitions, disposed, and ceased operations of ~~$12~~$87 million, the ~~increase~~remaining variation in net sales for the three months ended ~~December~~March 31, ~~2022~~2023 was ~~$39~~an increase of $32 million, or 1%, ~~driven by favorable~~reflecting price/mix benefit of 3%4% and unfavorable volumes of ~~(2%~~(3%).

Net income attributable to Amcor plc ~~increased~~decreased by ~~$234~~$92 million, or ~~104%~~34%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021,~~2022, mainly asfrom a ~~result of a pre-tax net gain of $215 million on disposal of the Russian business, increased~~decrease in gross profit of ~~$17~~$58 million, ~~generated by~~an increase in restructuring and related costs of $41 million, and higher net ~~sales improvement, partially offset by higher~~ interest expense of $40 ~~million.~~million, partially offset by a decrease in income tax expense of $38 million and a decrease in selling, general, and administrative expenses of $9 million.

Diluted earnings per share ("Diluted EPS") ~~increased~~decreased by ~~$0.159,~~$0.059, or ~~by 107%~~33%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021,~~2022, with the net income ~~attributable~~available to ordinary shareholders of Amcor plc ~~increasing~~decreasing by ~~104%~~34% and the diluted weighted average number of shares outstanding decreasing by 3%2%. The decrease in the diluted weighted-average number of shares outstanding was due to the repurchase of shares under previously announced share buyback programs.

Segment Results of Operations

Flexibles Segment


		Three Months Ended December 31,							Three Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Net sales	Net sales	$	2,812		$	2,713		Net sales	$	2,787		$	2,837
Adjusted EBIT	Adjusted EBIT	353			352			Adjusted EBIT	337			378
Adjusted EBIT as a percentage of net sales	Adjusted EBIT as a percentage of net sales	12.6		%	13.0		%	Adjusted EBIT as a percentage of net sales	12.1		%	13.3		%

Net sales ~~increased~~decreased by ~~$99~~$50 million, or ~~by 4%~~2%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~ 2022. Excluding the pass-through of higher raw material costs of ~~$193~~$33 million, negative currency impacts of ~~$158~~$59 million, and negative impact of acquisitions, disposed, and ceased operations of ~~$12~~$87 million, the ~~increase~~remaining variation in net sales for the three months ended ~~December~~March 31, ~~2022,~~2023, was ~~$76~~an increase of $63 million, or 3%2%, ~~driven by~~reflecting favorable price/mix of 4%5%, and unfavorable volumes of ~~(1%~~(3%).

Adjusted earnings before interest and tax ("Adjusted EBIT") ~~of $353~~decreased by $41 million or 11% for the three months ended ~~December~~March 31, ~~2022 was in line with $352 million for~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~2022. Excluding negative currency impacts of ~~$15~~$5 million and the negative net impact of acquisitions, disposed, and ceased operations of $2$31 million, the ~~increase~~remaining decrease in Adjusted EBIT for the three months ended ~~December~~March 31, ~~2022,~~2023, was ~~$18~~$5 million, or 5%1%, ~~driven by~~reflecting favorable price/mix of ~~16%~~20%, ~~partially~~more than offset by unfavorable volume of (8%), unfavorable plant costs of (10%), unfavorable SG&A and other costs of ~~(6%~~(3%), ~~unfavorable plant costs of (4%), both~~all largely impacted by inflationary ~~pressures, and unfavorable volumes of (1%).~~

pressures.

3637

Rigid Packaging Segment


		Three Months Ended December 31,							Three Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Net sales	Net sales	$	830		$	794		Net sales	$	880		$	871
Adjusted EBIT	Adjusted EBIT	57			55			Adjusted EBIT	69			77
Adjusted EBIT as a percentage of net sales	Adjusted EBIT as a percentage of net sales	6.9		%	6.9		%	Adjusted EBIT as a percentage of net sales	7.8		%	8.9		%

Net sales increased by ~~$36~~$9 million, or ~~by 4%~~1%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~2022. Excluding the pass-through of raw material costs of ~~$79~~$47 million and negative currency impacts of $6 million, the ~~decrease~~remaining variation in net sales for the three months ended ~~December~~March 31, ~~2022~~2023 was ~~$37~~a decrease of $32 million, or 5%4%, ~~driven by~~reflecting unfavorable volumes.

Adjusted EBIT ~~increased~~decreased by $2$8 million, or ~~by 5%~~10%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~ 2022. Excluding negative currency impacts of $1 million, the ~~increase~~remaining decrease in Adjusted EBIT for the three months ended ~~December~~March 31, ~~2022,~~2023, was $3$7 million, or 6%9%, ~~driven primarily by~~with favorable price/mix of ~~48%~~15%, ~~partially~~more than offset by unfavorable volumes of ~~(16%~~(15%), ~~unfavorable SG&A, and other costs of (19%) and~~ unfavorable plant costs of ~~(7%~~(6%) driven primarily by inflation on operating costs including higher energy and labor ~~costs.~~costs, and unfavorable SG&A and other costs of (3%).

Consolidated Gross Profit


		Three Months Ended December 31,							Three Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Gross profit	Gross profit	$	662		$	645		Gross profit	$	673		$	731
Gross profit as a percentage of net sales	Gross profit as a percentage of net sales	18.2		%	18.4		%	Gross profit as a percentage of net sales	18.4		%	19.7		%

Gross profit ~~increased~~decreased by ~~$17~~$58 million, or ~~by 3%~~8%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~ 2022. The ~~increase~~decrease was primarily driven by the ~~increase in net sales~~impact of ~~4% referred to above.~~disposed and ceased operations of $38 million, and lower volumes. Gross profit as a percentage of sales decreased to ~~18.2%~~18.4% for the three months ended ~~December~~March 31, ~~2022, primarily due to~~2023, mainly from the impact from disposed operations and the impact on the calculation from the ~~pass through~~pass-through of higher raw material costs during the current fiscal quarter.

Consolidated Selling, General, And Administrative Expenses


		Three Months Ended December 31,							Three Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Selling, general, and administrative expenses	Selling, general, and administrative expenses	$	(298)		$	(303)		Selling, general, and administrative expenses	$	(317)		$	(326)
Selling, general, and administrative expenses as a percentage of net sales	Selling, general, and administrative expenses as a percentage of net sales	(8.2)		%	(8.6)		%	Selling, general, and administrative expenses as a percentage of net sales	(8.6)		%	(8.8)		%

Selling, general, and administrative expenses decreased by $5$9 million, or ~~by 2%~~3%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021.~~2022. The decrease was primarily driven by ~~positive~~foreign currency ~~impacts during the three months ended December 31, 2022, partially offset by inflationary impacts on labor costs.~~exchange rate movements.

Consolidated Restructuring and Other Related Activities, Net
Three Months Ended December 31,
($ in millions) 2022 2021
Restructuring and related activities, net $ 213 $ (10)
Restructuring and related activities, net, as a percentage of net sales 5.8 % (0.3 %)


	Three Months Ended March 31,
($ in millions)	2023			2022
Restructuring and other related activities, net	$	(50)		$	(9)
Restructuring and other related activities, net, as a percentage of net sales	(1.4		%)	(0.2		%)

Restructuring and other related activities, net, ~~changed~~increased by ~~$223~~ $41 million for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021, mainly~~2022, primarily as a result of ~~a pre-tax net gain~~$42 million of ~~$215 million on~~restructuring and related costs recognized relating to the ~~disposal of the Russian business.~~2023 Restructuring Plan.

3738

Consolidated Interest ~~Expense~~
Three Months Ended December 31,
($ in millions) 2022 2021
Interest expense $ (79) $ (39)
Interest expense as a percentage of net sales (2.2 %) (1.1) %
Income


	Three Months Ended March 31,
($ in millions)	2023			2022
Interest income	$	15		$	5
Interest income as a percentage of net sales	0.4		%	0.1		%

Interest income increased by $10 million, or 200% for the three months ended March 31, 2023, compared to the three months ended March 31, 2022, driven by increased interest rates on cash balances.

Consolidated Interest Expense


	Three Months Ended March 31,
($ in millions)	2023			2022
Interest expense	$	(86)		$	(36)
Interest expense as a percentage of net sales	(2.3		%)	(1.0)		%

Interest expense increased by ~~$40~~$50 million, or ~~by 103%~~139%, for the three months ended ~~December~~March 31, ~~2022,~~2023, compared to the three months ended ~~December~~March 31, ~~2021,~~2022, driven by increased interest rates on ~~our~~ variable rate debt.

Consolidated Income Tax Expense


		Three Months Ended December 31,							Three Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Income tax expense	Income tax expense	$	(33)		$	(61)		Income tax expense	$	(34)		$	(72)
Effective income tax rate	Effective income tax rate	6.7		%	21.0		%	Effective income tax rate	16.0		%	21.0		%

The provision for income taxes for the three months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022 is based on our estimated annual effective tax rate for the respective fiscal years, and is applied on income before income taxes, and adjusted for specific items that are required to be recognized in the period in which they are incurred.

The effective tax rate for the three months ended ~~December~~March 31, ~~2022~~2023 decreased by ~~14.3~~5.0 percentage points compared to the three months ended ~~December~~March 31, ~~2021,~~2022, primarily due to differences in the the income mix ~~including higher non-taxable income in the current period,~~ and ~~the difference in magnitude of~~ discrete ~~events in both periods.~~events.

3839

Results of Operations - ~~Six~~Nine Months Ended ~~December~~March 31, ~~2022~~2023

Consolidated Results of Operations


		Six Months Ended December 31,							Nine Months Ended March 31,
($ in millions, except per share data)	($ in millions, except per share data)	2022			2021			($ in millions, except per share data)	2023			2022
Net sales	Net sales	$	7,354		$	6,927		Net sales	$	11,021		$	10,635
Operating income	Operating income	$	901		$	618		Operating income	$	1,183		$	987
Operating income as a percentage of net sales	Operating income as a percentage of net sales	12.3		%	8.9		%	Operating income as a percentage of net sales	10.7		%	9.3		%

Net income attributable to Amcor plc	Net income attributable to Amcor plc	$	691		$	427		Net income attributable to Amcor plc	$	868		$	696
Diluted Earnings Per Share	Diluted Earnings Per Share	$	0.461		$	0.279		Diluted Earnings Per Share	$	0.581		$	0.456

Net sales increased by ~~$427~~$386 million, or 6%4%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. Excluding the pass-through of raw material costs of ~~$670~~$750 million, negative currency impacts of ~~$371~~$438 million, and negative impact of acquisitions, disposed, and ceased operations of ~~$21~~$108 million, the remaining increase in net sales for the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 was ~~$149~~$182 million, or 2%, ~~driven by~~reflecting favorable price/mix of 3%4% and unfavorable volumes of ~~(1%~~(2%).

Net income attributable to Amcor plc increased by ~~$264~~$172 million, or ~~62%~~25%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021~~ 2022 mainly as a result of a pre-tax net gain of $215 million on the disposal of the Russian business ~~increased gross profit~~and a decrease in income tax expense of ~~$35 million and lower selling, general, and administrative expenses of $16~~$71 million, partially offset by ~~higher~~a decrease in gross profit of $23 million and an increase in net interest expense of ~~$59~~$89 million.

Diluted earnings per share increased by ~~$0.182,~~$0.125, or ~~by 65%~~27%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021,~~2022, with the net income ~~attributable~~available to ordinary shareholders of Amcor plc increasing by ~~62%~~24% and the diluted weighted average number of shares outstanding decreasing 3% for the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. The decrease in the diluted weighted average number of shares outstanding was due to the repurchase of shares under previously announced share buyback programs.

Segment Results of Operations

Flexibles Segment


		Six Months Ended December 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Net sales	Net sales	$	5,591		$	5,347		Net sales	$	8,378		$	8,184
Adjusted EBIT	Adjusted EBIT	$	706		$	691		Adjusted EBIT	$	1,043		$	1,069
Adjusted EBIT as a percentage of net sales	Adjusted EBIT as a percentage of net sales	12.6		%	12.9		%	Adjusted EBIT as a percentage of net sales	12.4		%	13.1		%

Net sales increased by ~~$244~~$194 million, or ~~by 5%~~2%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~ 2022. Excluding the pass-through of raw material costs of ~~$459~~$492 million, negative currency impacts of ~~$359~~$419 million, and negative impact of acquisitions, disposed, and ceased operations of ~~$21~~$108 million, the remaining increase in net sales for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, was ~~$165~~$229 million, or 3%, ~~driven by~~reflecting favorable price/mix of 4%5%, and unfavorable volumes of ~~(1%~~(2%).

Adjusted EBIT ~~increased~~decreased by ~~$15~~$26 million, or by 2%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~ 2022. Excluding negative currency impacts of ~~$36~~$41 million and the negative impact of acquisitions, disposed, and ceased operations of $4$34 million, the ~~increase~~remaining variation in Adjusted EBIT for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, was ~~$55~~an increase of $49 million, or 8%5%, ~~driven by~~reflecting favorable price/mix of 18%, partially offset by unfavorable volumes of (3%), unfavorable plant costs of (6%), unfavorable SG&A and other costs of ~~(5%), unfavorable plant costs of~~ (4%), ~~both~~all largely impacted by inflationary ~~pressures, and unfavorable volumes of (1%).~~pressures.

3940

Rigid Packaging Segment


		Six Months Ended December 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Net sales	Net sales	$	1,763		$	1,580		Net sales	$	2,643		$	2,451
Adjusted EBIT	Adjusted EBIT	$	123		$	117		Adjusted EBIT	$	192		$	194
Adjusted EBIT as a percentage of net sales	Adjusted EBIT as a percentage of net sales	7.0		%	7.4		%	Adjusted EBIT as a percentage of net sales	7.3		%	7.9		%

Net sales increased by ~~$183~~$192 million, or ~~by 12%~~8%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. Excluding the pass-through of raw material costs of ~~$211~~$258 million and negative currency impacts of ~~$12~~$18 million, the ~~decrease~~remaining variation in net sales for the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 was ~~$16~~a decrease of $48 million, or 2%, reflecting favorable price/mix of 1%, offset by unfavorable volume of (3%).

Adjusted EBIT decreased by $2 million, or 1%, ~~driven by favorable price/mix of 1% and unfavorable volumes of (2%).~~

~~Adjusted EBIT increased by $6 million, or by 5%,~~ for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. Excluding negative currency impacts of $1$2 million, ~~the increase in~~ Adjusted EBIT for the ~~six~~nine months ended ~~December~~March 31, 2023, was in line with Adjusted EBIT for the nine months ended March 31, 2022, ~~was $7 million, or 7%, driven primarily by~~reflecting favorable price/mix of ~~40%~~30%, ~~partially~~ offset by unfavorable volumes of ~~(3%~~(8%), unfavorable plant costs of (13%), and unfavorable SG&A and other costs of ~~(12%~~(9%) ~~and unfavorable plant costs of (18%) driven primarily by inflation on operating costs including higher energy and labor costs.~~.

Consolidated Gross Profit


		Six Months Ended December 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Gross profit	Gross profit	$	1,330		$	1,295		Gross profit	$	2,003		$	2,026
Gross profit as a percentage of net sales	Gross profit as a percentage of net sales	18.1		%	18.7		%	Gross profit as a percentage of net sales	18.2		%	19.1		%

Gross profit ~~increased~~decreased by ~~$35~~$23 million, or ~~by 3%~~1%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021. The~~2022. Excluding negative currency impacts of $77 million, the negative impact from disposed and ceased operations of $45 million, the remaining variation in gross profit for the nine months ended March 31, 2023 was an increase ~~was primarily driven by the increase in net sales~~ of ~~6% referred to above.~~$99 million, reflecting favorable operating cost initiatives. Gross profit as a percentage of sales decreased to ~~18.1%~~ 18.2% for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, primarily due to the impact on the calculation from the pass-through of higher raw material costs during the current fiscal ~~quarter~~period.

Consolidated Selling, General, and Administrative ("SG&A") Expenses


		Six Months Ended December 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
SG&A expenses	SG&A expenses	$	(600)		$	(616)		SG&A expenses	$	(917)		$	(942)
SG&A expenses as a percentage of net sales	SG&A expenses as a percentage of net sales	(8.2		%)	(8.9		%)	SG&A expenses as a percentage of net sales	(8.3		%)	(8.9		%)

SG&A expenses decreased by ~~$16~~$25 million, or by 3%, for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. The decrease was primarily driven by foreign currency ~~movements during the six months ended December 31, 2022, partially offset by inflationary impacts on labor costs.~~exchange rate movements.

Consolidated Restructuring and Other Related Activities, Net
Six Months Ended December 31,
($ in millions) 2022 2021
Restructuring and related activities, net $ 212 $ (18)
Restructuring and related activities, net, as a percentage of net sales 2.9 % (0.3 %)


	Nine Months Ended March 31,
($ in millions)	2023			2022
Restructuring and other related activities, net	$	162		$	(27)
Restructuring and other related activities, net, as a percentage of net sales	1.5		%	(0.3		%)

Restructuring and other related activities, net, ~~changed~~are favorable by ~~$230~~$189 million for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~ 2022. The change was mainly a result of a pre-tax net gain of $215 million on the disposal of the Russian ~~business.~~business, partially offset by an increase in restructuring and related costs of $42 million related to the 2023 Restructuring Plan.

4041

Consolidated Interest ~~Expense~~
Six Months Ended December 31,
($ in millions) 2022 2021
Interest expense $ (138) $ (79)
Interest expense as a percentage of net sales (1.9 %) (1.1 %)
Income


	Nine Months Ended March 31,
($ in millions)	2023			2022
Interest income	$	35		$	15
Interest income as a percentage of net sales	0.3		%	0.1		%

Interest ~~expense~~income increased by ~~$59~~$20 million, or ~~by 75%,~~133% for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021,~~ 2022, driven by increased interest rates on ~~our~~cash balances.

Consolidated Interest Expense


	Nine Months Ended March 31,
($ in millions)	2023			2022
Interest expense	$	(224)		$	(115)
Interest expense as a percentage of net sales	(2.0		%)	(1.1		%)

Interest expense increased by $109 million, or 95%, for the nine months ended March 31, 2023, compared to the nine months ended March 31, 2022, driven by increased interest rates on variable rate debt.

Consolidated Income Tax Expense


		Six Months Ended December 31,							Nine Months Ended March 31,
($ in millions)	($ in millions)	2022			2021			($ in millions)	2023			2022
Income tax expense	Income tax expense	$	(91)		$	(124)		Income tax expense	$	(125)		$	(196)
Effective income tax rate	Effective income tax rate	11.6		%	22.3		%	Effective income tax rate	12.5		%	21.8		%

The provision for income taxes for the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022 is based on our estimated annual effective tax rate for the respective fiscal years, ~~before~~and is applied on income before income taxes and adjusted for specific items that are required to be recognized in the period in which they are incurred.

The effective tax rate for the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 decreased by ~~10.7~~9.3 percentage points compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021,~~2022, primarily due to the non-taxable gain on the sale of the Russian business, differences in the income mix ~~including higher non-taxable income in the current period,~~ and ~~the difference in magnitude of~~ discrete ~~events in both periods.~~events.

4142

Presentation of Non-GAAP Information

This Quarterly Report on Form 10-Q refers to non-GAAP financial measures: adjusted earnings before interest and taxes ("Adjusted EBIT"), earnings before interest and tax ("EBIT"), adjusted net income, and net debt. Such measures have not been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These non-GAAP financial measures adjust for factors that are unusual or unpredictable. These measures exclude the impact of significant tax reforms, certain amounts related to the effect of changes in currency exchange rates, acquisitions, and restructuring, including employee-related costs, equipment relocation costs, accelerated depreciation, and the write-down of equipment. These measures also exclude gains or losses on sales of significant property and divestitures, significant property and other impairments, net of insurance recovery, certain litigation matters, significant pension settlements, impairments in goodwill and equity method investments, and certain acquisition-related expenses, including transaction expenses, due diligence expenses, professional and legal fees, purchase accounting adjustments for inventory, order backlog, intangible amortization, changes in the fair value of deferred acquisition payments and economic hedging instruments on commercial paper, and impacts related to the Russia-Ukraine conflict. We note that while amortization of acquired intangible assets is excluded from non-GAAP adjusted financial measures, the revenue of the acquired entities and all other expenses unless otherwise stated, are reflected in Adjusted EBIT and adjusted net income and the acquired assets contribute to revenue generation.

This adjusted information should not be construed as an alternative to results determined in accordance with U.S. GAAP. We use the non-GAAP measures to evaluate operating performance and believe that these non-GAAP measures are useful to enable investors and other external parties to perform comparisons of our current and historical performance.

A reconciliation of reported net income attributable to Amcor plc to EBIT, Adjusted EBIT, and Adjusted net income for the three and ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021~~2022 is as follows:


		Three Months Ended December 31,				Six Months Ended December 31,					Three Months Ended March 31,				Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		2022		2021		($ in millions)	2023		2022		2023		2022
Net income attributable to Amcor plc, as reported	Net income attributable to Amcor plc, as reported	$	459	$	225	$	691	$	427	Net income attributable to Amcor plc, as reported	$	177	$	269	$	868	$	696
Add: Net income attributable to non-controlling interests	Add: Net income attributable to non-controlling interests	2		4		4		5		Add: Net income attributable to non-controlling interests	2		2		6		7

Net income	Net income	461		229		695		432		Net income	179		271		874		703
Add: Income tax expense	Add: Income tax expense	33		61		91		124		Add: Income tax expense	34		72		125		196
Add: Interest expense	Add: Interest expense	79		39		138		79		Add: Interest expense	86		36		224		115
Less: Interest income	Less: Interest income	(11)		(5)		(20)		(10)		Less: Interest income	(15)		(5)		(35)		(15)
EBIT	EBIT	562		324		904		625		EBIT	284		374		1,188		999
Add: Material restructuring programs (1)		—		10		—		17
Add: 2019 Bemis Integration Plan										Add: 2019 Bemis Integration Plan	—		9		—		26
Add: Amortization of acquired intangible assets from business combinations ~~(2)~~(1)	Add: Amortization of acquired intangible assets from business combinations ~~(2)~~(1)	40		41		80		82		Add: Amortization of acquired intangible assets from business combinations ~~(2)~~(1)	40		40		120		122
Add: Impact of hyperinflation ~~(3)~~(2)	Add: Impact of hyperinflation ~~(3)~~(2)	5		2		13		4		Add: Impact of hyperinflation ~~(3)~~(2)	6		6		19		10
Add: Net loss on disposals ~~(4)~~(3)	Add: Net loss on disposals ~~(4)~~(3)	—		9		—		9		Add: Net loss on disposals ~~(4)~~(3)	—		—		—		9
Add/(Less): Property and other (gains)/losses, net (5)	Add/(Less): Property and other (gains)/losses, net (5)	—		(1)		—		27		Add/(Less): Property and other (gains)/losses, net (5)	—		(4)		—		23
Add: Pension settlement ~~(6)~~(5)	Add: Pension settlement ~~(6)~~(5)	—		3		—		3		Add: Pension settlement ~~(6)~~(5)	—		—		—		3
Less: Russia-Ukraine conflict impacts (7)		(207)		—		(204)		—
Add/(Less): Other (8)		(1)		—		(2)		2
Add/(Less): Russia-Ukraine conflict impacts (6)										Add/(Less): Russia-Ukraine conflict impacts (6)	48		—		(156)		—
Add: Other (7)										Add: Other (7)	4		2		2		4
Adjusted EBIT	Adjusted EBIT	$	399	$	388	$	791	$	769	Adjusted EBIT	$	382	$	427	$	1,173	$	1,196
Less: Income tax expense	Less: Income tax expense	(33)		(61)		(91)		(124)		Less: Income tax expense	(34)		(72)		(125)		(196)
Less: Adjustments to income tax expense ~~(9)~~(8)	Less: Adjustments to income tax expense ~~(9)~~(8)	(19)		(12)		(30)		(23)		Less: Adjustments to income tax expense ~~(9)~~(8)	(15)		(13)		(45)		(36)
Less: Interest expense	Less: Interest expense	(79)		(39)		(138)		(79)		Less: Interest expense	(86)		(36)		(224)		(115)
Add: Interest income	Add: Interest income	11		5		20		10		Add: Interest income	15		5		35		15
Less: Net income attributable to non-controlling interests	Less: Net income attributable to non-controlling interests	(2)		(4)		(4)		(5)		Less: Net income attributable to non-controlling interests	(2)		(2)		(6)		(7)
Adjusted net income	Adjusted net income	$	277	$	277	$	548	$	548	Adjusted net income	$	260	$	309	$	808	$	857

(1)~~Material restructuring programs includes restructuring and related expenses for the 2019 Bemis Integration Plan for the three and six months ended December 31, 2021.~~

~~(2)~~Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from past acquisitions.

~~(3)~~

(2)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.

~~(5)~~(4)Property and other (gains)/losses, net includes property and related business losses primarily associated with the destruction of our Durban, South Africa facility during general civil unrest in July 2021, net of insurance recovery.

~~(9)~~(8)Net tax impact on items (1) through ~~(8)~~(7) above.

Reconciliation of Net Debt

A reconciliation of total debt to net debt ~~at December~~as of March 31, ~~2022~~2023 and June 30, 2022 is as follows:


($ in millions)	($ in millions)	December 31, 2022		June 30, 2022		($ in millions)	March 31, 2023		June 30, 2022
Current portion of long-term debt	Current portion of long-term debt	$	14	$	14	Current portion of long-term debt	$	13	$	14
Short-term debt	Short-term debt	48		136		Short-term debt	196		136
Long-term debt, less current portion	Long-term debt, less current portion	6,840		6,340		Long-term debt, less current portion	6,804		6,340
Total debt	Total debt	6,902		6,490		Total debt	7,013		6,490
Less cash and cash equivalents	Less cash and cash equivalents	837		775		Less cash and cash equivalents	564		775
Net debt	Net debt	$	6,065	$	5,715	Net debt	$	6,449	$	5,715

4344

Supplemental Guarantor Information

Amcor plc, along with certain wholly owned subsidiary guarantors, guarantee the following senior notes issued by the wholly owned subsidiaries, Amcor Flexibles North America, Inc. and Amcor UK Finance plc.

• $500 million, 4.000%, Guaranteed Senior Notes due 2025 of Amcor Flexibles North America, Inc.

• $300 million, 3.100%, Guaranteed Senior Notes due 2026 of Amcor Flexibles North America, Inc.

• $600 million, 3.625%, Guaranteed Senior Notes due 2026 of Amcor Flexibles North America, Inc.

• $500 million, 4.500%, Guaranteed Senior Notes due 2028 of Amcor Flexibles North America, Inc.

• $500 million, 2.630%, Guaranteed Senior Notes due 2030 of Amcor Flexibles North America, Inc.

• $800 million, 2.690%, Guaranteed Senior Notes due 2031 of Amcor Flexibles North America, Inc.

• €500 million, 1.125%, Guaranteed Senior Notes due 2027 of Amcor UK Finance plc

The six notes issued by Amcor Flexibles North America, Inc. are guaranteed by its parent entity Amcor plc and the subsidiary guarantors Amcor Pty Ltd, Amcor Finance (USA), Inc., and Amcor UK Finance plc. The note issued by Amcor UK Finance plc is guaranteed by its parent entity, Amcor plc and the subsidiary guarantors Amcor Pty Ltd, Amcor Flexibles North America, Inc., and Amcor Finance (USA), Inc.

All guarantors fully, unconditionally, and irrevocably guarantee, on a joint and several basis, to each holder of the notes, the due and punctual payment of the principal of, and any premium and interest on, such note and all other amounts payable, when and as the same shall become due and payable, whether at stated maturity, by declaration of acceleration, call for redemption or otherwise, in accordance with the terms of the notes and related indenture. The obligations of the applicable guarantors under their guarantees will be limited as necessary to recognize certain defenses generally available to guarantors (including those that relate to fraudulent conveyance or transfer, voidable preference, financial assistance, corporate purpose, or similar laws) under applicable law. The guarantees will be unsecured and unsubordinated obligations of the guarantors and will rank equally with all existing and future unsecured and unsubordinated debt of each guarantor. None of our other subsidiaries guarantee ~~such~~these notes. The issuers and guarantors conduct large parts of their operations through other subsidiaries of Amcor plc.

Amcor Flexibles North America, Inc. is incorporated in Missouri in the United States, Amcor UK Finance plc is incorporated in England and Wales, United Kingdom, and the guarantors are incorporated under the laws of Jersey, Australia, the United States, and England and Wales and, therefore, insolvency proceedings with respect to the issuers and guarantors could proceed under, and be governed by, among others, Jersey, Australian, United States, or English insolvency law, as the case may be, if either issuer or any guarantor defaults on its obligations under the applicable Notes or Guarantees, respectively.

Set forth below is the summarized financial information of the combined Obligor Group made up of Amcor plc (as parent guarantor), Amcor Flexibles North America, Inc. and Amcor UK Finance plc (as subsidiary issuers of the notes and guarantors of each other’s notes), and Amcor Finance (USA), Inc. and Amcor Pty Ltd (as the remaining subsidiary guarantors).

4445

Basis of Preparation

The following summarized financial information is presented for the parent, issuer, and guarantor subsidiaries ("Obligor Group") on a combined basis after elimination of intercompany transactions between entities in the combined group and amounts related to investments in any subsidiary that is a non-guarantor.

This information is not intended to present the financial position or results of operations of the combined group of companies in accordance with U.S. GAAP.

Statement of Income for Obligor Group


($ in millions)	~~Six~~Nine Months Ended ~~December~~March 31, ~~2022~~2023
Net sales - external	$	~~542~~812
Net sales - to subsidiaries outside the Obligor Group	34
Total net sales	~~545~~816

Gross profit	87137





Net income	$	~~(244)~~(59)

Net income attributable to non-controlling interests	—

Net income attributable to Obligor Group	$	~~(244)~~(59)

Balance Sheets for Obligor Group


($ in millions)	($ in millions)	December 31, 2022		June 30, 2022		($ in millions)	March 31, 2023		June 30, 2022
Assets	Assets					Assets
Current assets - external	Current assets - external	$	859	$	1,254	Current assets - external	$	777	$	1,254
Current assets - due from subsidiaries outside the Obligor Group	Current assets - due from subsidiaries outside the Obligor Group	122		83		Current assets - due from subsidiaries outside the Obligor Group	94		83
Total current assets	Total current assets	981		1,337		Total current assets	871		1,337
Non-current assets - external	Non-current assets - external	1,394		1,396		Non-current assets - external	1,394		1,396
Non-current assets - due from subsidiaries outside the Obligor Group	Non-current assets - due from subsidiaries outside the Obligor Group	10,179		10,978		Non-current assets - due from subsidiaries outside the Obligor Group	9,535		10,978
Total non-current assets	Total non-current assets	11,573		12,374		Total non-current assets	10,929		12,374
Total assets	Total assets	$	12,554	$	13,711	Total assets	$	11,800	$	13,711
Liabilities	Liabilities					Liabilities
Current liabilities - external	Current liabilities - external	$	1,279	$	2,014	Current liabilities - external	$	1,434	$	2,014
Current liabilities - due to subsidiaries outside the Obligor Group	Current liabilities - due to subsidiaries outside the Obligor Group	30		23		Current liabilities - due to subsidiaries outside the Obligor Group	19		23
Total current liabilities	Total current liabilities	1,309		2,037		Total current liabilities	1,453		2,037
Non-current liabilities - external	Non-current liabilities - external	6,981		6,456		Non-current liabilities - external	6,922		6,456
Non-current liabilities - due to subsidiaries outside the Obligor Group	Non-current liabilities - due to subsidiaries outside the Obligor Group	10,246		11,255		Non-current liabilities - due to subsidiaries outside the Obligor Group	9,523		11,255
Total non-current liabilities	Total non-current liabilities	17,227		17,711		Total non-current liabilities	16,445		17,711
Total liabilities	Total liabilities	$	18,536	$	19,748	Total liabilities	$	17,898	$	19,748

4546

New Accounting Pronouncements

Refer to Note 2, "New Accounting Guidance," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements."

Critical Accounting Estimates and Judgments

Our discussion and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Our estimates and judgments are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. These critical accounting estimates are discussed in detail in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates and Judgments” in our Annual Report on Form 10-K for the year ended June 30, 2022. There have been no material changes in critical accounting estimates and judgments as of ~~December~~March 31, ~~2022~~2023 from those described in our Annual Report on Form 10-K for the year ended June 30, 2022.

4647

Liquidity and Capital Resources

We finance our business primarily through cash flows provided by operating activities, borrowings from banks, and proceeds from issuances of debt and equity. We periodically review our capital structure and liquidity position in light of market conditions, expected future cash flows, potential funding requirements for debt refinancing, capital expenditures and acquisitions, the cost of capital, sensitivity analyses reflecting downside scenarios, the impact on our financial metrics and credit ratings, and our ease of access to funding sources.

On March 22, 2023, we redeemed Euro bonds of a principal amount of €300 million (equivalent to $322 million) at maturity. The ~~COVID-19 pandemic and geopolitical tensions have not materially impacted our liquidity position, current and expected cash flows from operating activities, or available cash.~~redemption was funded with commercial paper. The notes carried an interest rate of 2.75%.

We believe that our cash flows provided by operating activities, together with borrowings available under our credit facilities and access to the commercial paper market, backstopped by our bank debt facilities, will continue to provide sufficient liquidity to fund our operations, capital expenditures, and other commitments, including dividends and purchases of our ordinary shares and CHESS Depositary Instruments under authorized share repurchase programs, into the foreseeable future.

Overview


		Six Months Ended December 31,					Nine Months Ended March 31,
($ in millions)	($ in millions)	2022		2021		($ in millions)	2023		2022
Net cash provided by operating activities	Net cash provided by operating activities	$	145	$	323	Net cash provided by operating activities	$	329	$	589
Net cash (used in)/provided by investing activities		24		(265)
Net cash used in financing activities		(90)		(235)
Net cash used in investing activities						Net cash used in investing activities	(149)		(383)
Net cash provided by/(used in) financing activities						Net cash provided by/(used in) financing activities	(372)		52

Cash Flow Overview

Net Cash Provided by Operating Activities

Net cash provided by operating activities decreased by ~~$178~~$260 million for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. The decrease in cash flow is primarily driven by higher working capital outflows in the current ~~period.~~period and by lower net income after excluding a non-cash gain on the sale of our Russian business.

Net Cash ~~(Used in)/Provided by~~Used in Investing Activities

Net cash used ~~in/provided by~~in investing activities ~~increased~~decreased by ~~$289~~$234 million for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. The ~~increase~~decrease is mainly driven by the disposal proceeds collected from the sale of the Russian business in the current period, partially offset by the ~~acquisition~~acquisitions of DGPack s.r.o. and MDK Packaging Materials Co., Ltd, and additional investments in affiliated companies.

Net Cash ~~Used in~~Provided by/(used in) Financing Activities

Net cash ~~used in~~from financing activities decreased by ~~$145~~$424 million for the ~~six~~nine months ended ~~December~~March 31, ~~2022,~~2023, compared to the ~~six~~nine months ended ~~December~~March 31, ~~2021.~~2022. The change is primarily due to lower ~~share buybacks compared to the prior period,~~net debt drawdowns, partially offset by lower ~~net debt drawdowns~~share buybacks in the current period as compared to the prior period.

Net Debt

We borrow from financial institutions and debt investors in the form of bank overdrafts, bank loans, corporate bonds, unsecured notes, and commercial paper. We have a mixture of fixed and floating interest rates and use interest rate swaps to provide further flexibility in managing the interest cost of borrowings.

At the end of October 2022, we entered into two interest rate swap contracts for a total notional amount of $1.25 billion. Under the terms of the contracts, we will pay a weighted average fixed rate of interest of 4.53% and receive a variable rate of interest, based on compound overnight SOFR, ~~for the period~~ from November 1, 2022, through June 30, 2023, settled monthly. In March 2023, we entered into another two interest rate swap contracts for a total notional amount of $1.2 billion. Under the terms of the contracts, we will pay a weighted average fixed rate of interest of 3.88% and receive a variable rate of interest based on 1-month Term SOFR. The swaps are effective as of July 1, 2023, and mature on June 30, 2024. The interest rate swap contracts economically hedge the SOFR component of ~~$1.25 billion of ongoing USD~~our forecasted commercial paper ~~issuances at 4.53%.~~issuances.

Short-term debt consists of bank debt with a duration of less than 12 months and bank overdrafts which are classified as current due to the short-term nature of the borrowings, except where we have the ability and intent to refinance and as such extend the debt beyond 12 months. The current portion of long-term debt consists of debt amounts repayable within a year after the balance sheet date.

Our primary bank debt facilities and notes are unsecured and subject to negative pledge arrangements limiting the amount of secured indebtedness we can incur to 10.0% of our total tangible assets, subject to some exceptions and variations by facility. In addition, the covenants of the bank debt facilities require us to maintain a leverage ratio not higher than 3.9 times. The negative pledge arrangements and the financial covenants are defined in the related debt agreements. As of ~~December~~March 31, ~~2022,~~2023, we were in compliance with all applicable covenants under our bank debt facilities.

Our net debt as of ~~December~~March 31, ~~2022~~2023 and June 30, 2022 was ~~$6.1~~$6.4 billion and $5.7 billion, respectively.

Available Financing

As of ~~December~~March 31, ~~2022,~~2023, we had undrawn credit facilities available in the amount of ~~$0.9~~$0.7 billion. Our senior facilities are available to fund working capital, growth capital expenditures, and refinancing obligations and are provided to us by two bank syndicates. These facilities mature in April 2025 and April 2027, respectively, and the revolving tranches have two 12-month options available to management to extend the maturity date. Subject to certain conditions, we can request the total commitment level under each agreement to be increased by up to $500 million.

As of ~~December~~March 31, ~~2022,~~2023, the revolving senior bank debt facilities had an aggregate limit of $3.8 billion, of which ~~$2.9~~$3.1 billion had been drawn (inclusive of amounts drawn under commercial paper programs reducing the overall balance of available senior facilities).

Dividend Payments

We declared and paid a $0.12 cash dividend per ordinary share during the first fiscal quarter that ended September 30, 2022, ~~and~~ a $0.1225 cash dividend per ordinary share during the second fiscal quarter that ended December 31, ~~2022.~~2022, and a $0.1225 cash dividend per ordinary share during the third fiscal quarter that ended March 31, 2023.

Credit Rating

Our capital structure and financial practices have earned us investment grade credit ratings from two internationally recognized credit rating agencies. These investment grade credit ratings are important to our ability to issue debt at favorable rates of interest, for various terms, and from a diverse range of markets that are highly liquid, including European and U.S. debt capital markets, and from global financial institutions.

Share Repurchases

On August 17, 2022, our Board of Directors approved a $400 million buyback of ordinary shares and/or CHESS Depositary Instruments ("CDIs"). During the six months ended December 31, 2022, we repurchased approximately $40 million of ordinary shares and CDIs in the aggregate, including transaction costs, or 3 million shares. The shares repurchased as part of the program were canceled upon repurchase. Further, on February 7, 2023, our Board of Directors approved an additional buyback of up to $100 million of ordinary shares and/or ~~CHESS Depositary Instruments ("CDIs")~~CDIs in the following twelve months. During the nine months ended March 31, 2023, we repurchased approximately $200 million of ordinary shares and CDIs in the aggregate, including transaction costs, or 18 million shares. The shares repurchased as part of the program were canceled upon repurchase.

We had cash outflows of $221 million and $133 million for the purchase of our shares in the open market and using forward contracts to purchase our own equity during the ~~six~~nine months ended ~~December~~March 31, ~~2022~~2023 and ~~2021,~~2022, respectively, as treasury shares to satisfy the vesting and exercises of share-based compensation awards. As of ~~December~~March 31, ~~2022~~2023 and June 30, 2022, we held treasury shares at a cost of $14 million and $18 million, representing 1 million and 2 million ~~shares.~~shares, respectively.

4849

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our market risk during the three and nine months ended ~~December~~March 31, ~~2022.~~2023. For additional information, refer to Note 8, "Fair Value Measurements," and Note 9, "Derivative Instruments," in the notes to our unaudited condensed consolidated financial statements, and to "Item 7A. - Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the year ended June 30, 2022.

4950

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of ~~December~~March 31, ~~2022.~~2023. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of ~~December~~March 31, ~~2022.~~2023.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the ~~second~~third quarter of fiscal year 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

5051

Part II - Other Information

Item 1. Legal Proceedings

The material set forth in Note ~~15,~~16, "Contingencies and Legal Proceedings," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements" is incorporated herein by reference.

Item 1A. Risk Factors

There have been no material changes from the risk factors contained in "Item 1A. - Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Share Repurchases

Share repurchase activity during the three months ended ~~December~~March 31, ~~2022~~2023 was as follows (in millions, except number of shares, which are reflected in thousands, and per share amounts, which are expressed in U.S. dollars):

Period Total Number of Shares Purchased (1) Average Price Paid Per Share (1)(2) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares That May Yet Be Purchased Under the Programs (3)
October 1 - 31, 2022 — $ — — $ 400
November 1 - 30, 2022 131 12.52 — 400
December 1 - 31, 2022 4,632 12.50 3,240 360
Total 4,763 $ 12.50 3,240


Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share (1)(2)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Programs (3)
January 1 - 31, 2023	—	$	—	—	$	360
February 1 - 28, 2023	5,961	11.33		5,961	392
March 1 - 31, 2023	8,375	11.03		8,375	300
Total	14,336	$	11.15	14,336

(1) Includes shares purchased on the open market to satisfy the vesting and exercises of share-based compensation awards.

(2) Average price paid per share excludes costs associated with the repurchases.

(3) On August 17, 2022, our Board of Directors approved a buyback of $400 million of ordinary shares and/or CHESS Depositary Instruments ("CDIs") during the following twelve months. Further, on February 7, 2023, our Board of Directors approved an additional buyback of up to $100 million of ordinary shares and CDIs during the following twelve months. The timing, volume, and nature of share repurchases may be amended, suspended, or discontinued at any time.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

5152

Item 6. Exhibits

The documents in the accompanying Exhibits Index are filed, furnished, or incorporated by reference as part of this Quarterly Report on Form 10-Q, and such Exhibits Index is incorporated herein by reference.


Exhibit		Description
22		Subsidiary Guarantors and Issuers of Guaranteed Securities.
31	.1	Chief Executive Officer Certification required by Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended.
31	.2	Chief Financial Officer Certification required by Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended.
32		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes Oxley Act of 2002.
101	.INS	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document.
101	.SCH	Inline XBRL Taxonomy Extension Schema Document.
101	.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101	.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101	.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101	.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

5253

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			AMCOR PLC


Date	~~February 8,~~May 3, 2023	By	/s/ Michael Casamento
			Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer)

Date	~~February 8,~~May 3, 2023	By	/s/ Julie Sorrells
			Julie Sorrells, Vice President and Corporate Controller (Principal Accounting Officer)

5354